New version of CIEL concept dictionary added to dropbox

akanter · August 18, 2022, 3:29am

New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for August 14, 2022!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.4, 1.8.3, 1.9.12, 1.10.2, 1.11.4, 2.0.1, 2.1, 2.2, 2.3, 2.4 and 2.5.

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE .

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release includes many new concepts for The WHO ANC DTK, PIH, COVID-19, and several important concepts for documenting Monkeypox (disease and exposure) and vaccination. Please update your dictionaries.

It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.

The drug table was updated for this release, but will be distributed separately

concept_id	name	Class	Datatype	description
167440	Exposure to suspected case of monkeypox	Finding	N/A	\N
—	—	—	—	—
167439	Suspected monkeypox	Diagnosis	N/A	\N
167438	Administration of ACAM 2000 smallpox vaccine for monkeypox	Procedure	N/A	\N
167438	Administration of ACAM 2000 smallpox vaccine	Procedure	N/A	\N
167437	At increased risk of exposure to monkeypox virus	Finding	N/A	\N
167436	Close exposure to monkeypox virus	Finding	N/A	\N
167435	Administration of Jynneos smallpox and monkeypox vaccine	Procedure	N/A	\N
167434	Monkeypox confirmed using clinical diagnostic criteria	Diagnosis	N/A	\N
167433	Monkeypox excluded by laboratory test	Finding	N/A	\N
167432	Monkeypox excluded using clinical diagnostic criteria	Finding	N/A	\N
167431	Laboratory confirmed diagnosis of monkeypox	Diagnosis	N/A	\N
167430	Worse stage of retinopathy of prematurity (ROP)	Question	Coded	\N
167429	Perinatal intraventricular haemorrhage grade	Question	Coded	\N
167429	Perinatal intraventricular hemorrhage grade	Question	Coded	\N
167428	Perinatal intraventricular haemorrhage, grade 4	Diagnosis	N/A	\N
167428	Perinatal intraventricular hemorrhage, grade IV	Diagnosis	N/A	\N
167427	Anticonvulsant therapy	Procedure	N/A	\N
167426	Interventions received in newborn unit	ConvSet	N/A	\N
167425	Therapeutic hypothermia	Procedure	N/A	\N
167424	Cranial ultrasound	Test	N/A	\N
167423	Neonatal exchange transfusion	Procedure	N/A	\N
167422	Light therapy	Procedure	N/A	\N
167422	Phototherapy	Procedure	N/A	\N
167421	Screening for retinopathy of prematurity	Procedure	N/A	\N
167421	ROP screen	Procedure	N/A	\N
167420	Administration of methylxanthine for neonatal apnea	Procedure	N/A	\N
167419	Pulmonary surfactant replacement	Procedure	N/A	\N
167419	Pulmonary surfactant therapy	Procedure	N/A	\N
167418	Administration of delayed kangaroo mother care	Procedure	N/A	\N
167417	Administration of epinephrine for resuscitation	Procedure	N/A	\N
167416	Delivery room interventions performed	Test	N/A	\N
167415	CPR	Procedure	Coded	\N
167415	Cardiopulmonary resuscitation (CPR)	Procedure	Coded	\N
167414	Delivery room interventions	Question	Coded	\N
167413	Date of previous admission	Question	Datetime	\N
167413	Date of prior admission	Question	Datetime	\N
167412	History of hospitalization for severe acute respiratory syndrome coronavirus 2 disease (SARS-COV-2)	Finding	Coded	\N
167412	History of hospitalization for COVID-19	Finding	Coded	\N
167411	Triage	Misc	N/A	\N
167411	Triage service	Misc	N/A	\N
167410	Clinical consultation	Misc	N/A	\N
167410	Clinician-provided service	Misc	N/A	\N
167409	Service completed	Misc	N/A	\N
167409	Finished service	Misc	N/A	\N
167408	In service	Misc	N/A	Currently being cared for by service
167407	Waiting	Misc	N/A	\N
167406	Patient care administration status	Question	Coded	\N
167405	Presence of gram-positive bacilli in gram stain	Test	Coded	\N
167404	Arrangement of gram-positive cocci on gram stain	Test	Coded	\N
167403	Presence of gram-positive cocci on gram stain	Test	Coded	\N
167402	Finding of gram-positive cocci in chains	Finding	N/A	\N
167401	Finding of gram-positive cocci in clusters	Finding	N/A	\N
167400	Finding of gram-positive cocci in pairs	Finding	N/A	\N
167399	Arrangement of bacteria in specimen	Test	Coded	\N
167398	Yeast presence in specimen by gram stain	Test	Coded	\N
167397	Source of vaccination history information	Question	Coded	\N
167397	Source of immunization history information	Question	Coded	\N
167396	Stepdown unit	Misc	N/A	\N
167396	High dependency unit (HDU)	Misc	N/A	\N
167395	Admitted to location	Question	Coded	\N
167395	Admission to department location	Question	Coded	\N
167394	History of HIV-related opportunistic infections	Question	Coded	A field to capture history of HIV-related opportunistic infections experienced by patient.
167393	Isoniazid + Rifapentine	Misc	N/A	Drug regimen containing Isoniazid and Rifapentine
167393	Isoniazid / Rifapentine regimen	Misc	N/A	Drug regimen containing Isoniazid and Rifapentine
167392	Nutritional status	Question	Coded	\N
167391	Routine viral load	Procedure	N/A	\N
167390	Baseline viral load	Procedure	N/A	\N
167389	Recency assay	Procedure	N/A	Viral load testing is strongly recommended among those who test recent on TRI as part of recent infection testing algorithm (RITA).
167388	Confirmation of treatment failure	Procedure	N/A	\N
167387	Treatment failure	Finding	N/A	\N
167386	Early-onset neonatal sepsis	Finding	N/A	\N
167385	Sample rejected	Finding	N/A	\N
167384	Stimulation of newborn	Procedure	N/A	\N
167384	Neonatal stimulation	Procedure	N/A	\N
167383	Bag valve mask ventilation	Procedure	N/A	\N
167383	BVM	Procedure	N/A	\N
167382	Airway suctioning	Procedure	N/A	\N
167381	Patient meets trial/protocol criteria	Question	Coded	\N
167380	Treatment(s) dispensed or prescribed this encounter	Question	Coded	\N
167379	PLLV	Finding	N/A	A detectable viral load (above the LDL value) but < 1,000 copies/ml on two or more consecutive measures
167379	Persistent low-level viremia	Finding	N/A	A detectable viral load (above the LDL value) but < 1,000 copies/ml on two or more consecutive measures
167378	Low-level viremia	Finding	N/A	A detectable viral load (above the LDL value) but < 1,000 copies/ml
167378	LLV	Finding	N/A	A detectable viral load (above the LDL value) but < 1,000 copies/ml
167377	Studded epithelial cells, presence in body fluid	Test	Coded	\N
167376	Epithelial cells, presence in body fluid	Test	Coded	\N
167375	Urine drug screen positive in past 30 days	Finding	N/A	\N
167374	Religious faith healer	Misc	N/A	\N
167373	Duration of transfer/referral of care	Question	Coded	\N
167372	Temporary transfer of care	Procedure	N/A	\N
167371	Permanent transfer of care	Procedure	N/A	\N
167370	Current buprenorphine dose (mg)	Question	Numeric	\N
167369	Current dose of methadone (mg)	Question	Numeric	\N
167368	Type of memory loss	Question	Coded	\N
167367	Hemostatic hysterectomy postpartum	Procedure	N/A	\N
167367	Hysterectomy for postpartum hemorrhage	Procedure	N/A	\N
167367	Hysterectomy for postpartum haemorrhage	Procedure	N/A	\N
167366	Partial hysterectomy	Procedure	N/A	\N
167366	Subtotal hysterectomy	Procedure	N/A	\N
167365	Vibrio cholerae in stool by light microscopy	Test	Coded	\N
167364	Giardia lamblia in stool by light microscopy	Test	Coded	\N
167363	Entamoeba histolytica in stool by light microscopy	Test	Coded	\N
167362	Trichomonas intestinalis in stool by light microscopy	Test	Coded	\N
167361	Impairment of immediate recall	Finding	N/A	\N
167361	Impairment of registration (recall)	Finding	N/A	\N
167360	Dientamoeba fragilis in stool by iight microscopy	Test	Coded	\N
167359	Chilomastix mesnili in stool by light microscopy	Test	Coded	\N
167358	Entamoeba coli in stool by light microscopy	Test	Coded	\N
167357	Balantidium coli in stool by light microscopy	Test	Coded	\N
167356	Enterobius vermicularis in stool by light microscopy	Test	Coded	\N
167355	Strongyloide stercoralis in stool by light microscopy	Test	Coded	\N
167354	Beef tapeworm in stool by light microscopy	Test	Coded	\N
167354	Taenia saginata in stool by light microscopy	Test	Coded	\N
167353	Pork tapeworm in stool by light microscopy	Test	Coded	\N
167353	Taenia solium in stool by light microscopy	Test	Coded	\N
167352	Endolimax nana in stool by light microscopy	Test	Coded	\N
167351	Hymenolepis nana in stool by light microscopy	Test	Coded	\N
167350	Trichuris trichiura in stool by light microscopy	Test	Coded	\N
167349	Ancylostoma duodenale in stool by light microscopy	Test	Coded	\N
167348	Ascaris lumbricoides in stool by light microscopy	Test	Coded	\N
167347	Trichomonas intestinalis	Organism	N/A
167346	Dientamoeba fragilis	Organism	N/A	\N
167345	Chilomastix mesnili	Organism	N/A	\N
167344	Entamoeba coli	Organism	N/A	\N
167343	Balantidium coli	Organism	N/A	\N
167342	Pinworm	Organism	N/A	\N
167342	Threadworm	Organism	N/A	\N
167342	Enterobius vermicularis	Organism	N/A	\N
—	—	—	—	—
167341	Strongyloide stercoralis	Organism	N/A	\N
167340	Beef tapeworm	Organism	N/A	\N
167340	Taenia saginata	Organism	N/A	\N
167339	Pork tapeworm	Organism	N/A	\N
167339	Taenia solium	Organism	N/A	\N
167338	Endolimax nana	Organism	N/A	\N
167337	Hymenolepis nana	Organism	N/A	\N
167336	Trichuris trichiura	Organism	N/A	\N
167335	Ancylostoma duodenale	Organism	N/A	\N
167334	Stool examination for Ova and Parasite result	ConvSet	N/A	\N
167333	Quantity found on examination	Question	Coded	\N
167332	Many	Misc	N/A	\N
167332	Numerous	Misc	N/A	\N
167331	Ascaris lumbricoides	Organism	N/A	\N
167330	Stool for ova and parasites with concentration	Test	Coded	\N
167329	Ready to taper off opioid maintenance medication	Question	Coded	\N
167328	Remained on the same opioid maintenance dose for the past three months	Question	Coded	\N
167328	Remained on the same opioid maintenance dose for the last 3 months	Question	Coded	\N
167327	Stable income	Finding	Coded	\N
167326	Stopped engaging in criminal behavior	Question	Coded	\N
167326	Stopped engaging in criminal behaviour	Question	Coded	\N
167325	Comfortably resides in area away from drug-using sites	Question	Coded	\N
167324	Staying away from drug-using friends	Question	Coded	\N
167323	Able to cope with stressful situations without using drugs	Question	Coded	\N
167322	Employed	Finding	N/A	\N
167321	Patient memory ability	Question	Coded	\N
167321	Memory recall	Question	Coded	\N
167320	Logical thinking	Finding	N/A	\N
167319	Illogical thinking	Finding	N/A	\N
167318	Pressured thought	Finding	N/A	\N
167318	Pressure of thought	Finding	N/A	\N
167317	Elated	Finding	N/A	\N
167316	No involuntary movements	Finding	N/A	\N
167315	Uncooperative behavior	Finding	N/A	\N
167315	Uncooperative behaviour	Finding	N/A	\N
167315	Uncooperative	Finding	N/A	\N
167314	Withdrawal method of contraception	Finding	N/A	\N
167313	Fraud/Forgery	Finding	N/A	\N
167312	Robbery	Finding	N/A	\N
167311	Burglary/Larceny	Finding	N/A	\N
167310	Weapons offense	Finding	N/A	\N
167309	Drug possession	Finding	N/A	\N
167308	Drunk and disorderly conduct	Finding	N/A	\N
167307	History of violent behaviour	Finding	N/A	\N
167307	History of violent behavior	Finding	N/A	\N
167306	Education about possible consequences of non-compliance to Medically Assisted Therapy (MAT) agreements	Procedure	N/A	\N
167305	Education about dangers of continued use of substances while on Medically Assisted Therapy (MAT)	Procedure	N/A	\N
167304	BA.2.75 variant	Misc	N/A	\N
167304	Centaurus variant	Misc	N/A	\N
167303	Dependent drug detoxification therapy	Procedure	N/A	\N
167302	Population prevalence of hepatitis C	Question	Numeric	\N
167301	Population prevalence of hepatitis B	Question	Numeric	\N
167300	Population prevalence of syphilis in pregnant women	Question	Numeric	\N
167299	Population prevalence of HIV in pregnant women	Question	Numeric	\N
167298	Population prevalence of HIV in key populations	Question	Numeric	Population prevalence of HIV in key populations (men who have sex with men, people in prison or other closed settings, people who inject drugs, sex workers and transgender people)
167297	Population incidence of HIV (/100 person*years)	Question	Numeric	Population incidence of HIV in the absence of PrEP
167296	Population prevalence of soil-transmitted helminth infection	Question	Numeric	\N
167295	Population prevalence of tuberculosis (TB)	Question	Numeric	\N
167294	Population prevalence of anaemia	Question	Numeric	\N
167294	Population prevalence of anemia	Question	Numeric	\N
167293	Population prevalence of malnourishment	Question	Numeric	\N
167293	Population prevalence of undernourishment	Question	Numeric	\N
167292	BA.5 variant	Misc	N/A	\N
167291	BA.4 variant	Misc	N/A	\N
167290	BA.2.12.1 variant	Misc	N/A	\N
167289	BA.3 variant	Misc	N/A	\N
167288	BA.2 variant	Misc	N/A	\N
167287	Family medication required	Question	Coded	\N
167287	Family medication needed	Question	Coded	\N

akanter · October 23, 2022, 2:48am

New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for October 12, 2022! Sorry that I forgot to notify of the September release!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.11.4, 2.0.1, 2.1, 2.2, 2.3, 2.4 and 2.5. Note that I will no longer be releasing in version prior to 1.11

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE .

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release includes many new concepts for Oncology (drug ingredients) and a few new concepts for COVID. Please update your dictionaries.

It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.

The drug table was updated for this release, but will be distributed separately

concept_id	name	Class	Datatype	description
167619	Erismodegib	Drug	N/A	
167619	Odomzo	Drug	N/A	
167619	Sonidegib	Drug	N/A	
167618	Provenge	Drug	N/A	
167618	Sipuleucel-T	Drug	N/A	
167617	Retsevmo	Drug	N/A	
167617	Selpercatinib	Drug	N/A	
167617	Retevmo	Drug	N/A	
167616	Selinexor	Drug	N/A	
167616	Xpovio	Drug	N/A	
167615	Sacituzumab govitecan	Drug	N/A	
167615	Trodelvy	Drug	N/A	
167614	Jakavi	Drug	N/A	
167614	Opzelura	Drug	N/A	
167614	Jakafi	Drug	N/A	
167614	Ruxolitinib	Drug	N/A	
167613	Rubraca	Drug	N/A	
167613	Rucaparib	Drug	N/A	
167612	Romidepsin	Drug	N/A	
167612	Istodax	Drug	N/A	
167611	Rituxan Hycela	Drug	N/A	
167611	Hyaluronidase / rituximab	Drug	N/A	
167610	Ruxience	Drug	N/A	
167610	Rituximab-pvvr	Drug	N/A	
167609	Riabni	Drug	N/A	
167609	Rituximab-arrx	Drug	N/A	
167608	Truxima	Drug	N/A	
167608	Rituximab-abbs	Drug	N/A	
167607	Ripretinib	Drug	N/A	
167607	Qinlock	Drug	N/A	
167606	Ribociclib	Drug	N/A	
167606	Kisqali	Drug	N/A	
167606	Kryxana	Drug	N/A	
167605	Myfembree	Drug	N/A	
167605	Estradiol / norethindrone / relugolix	Drug	N/A	
167604	Relugolix	Drug	N/A	
167604	Relumina	Drug	N/A	
167604	Orgovyx	Drug	N/A	
167603	Regonix	Drug	N/A	
167603	Regorafenib	Drug	N/A	
167603	Renib	Drug	N/A	
167603	Resihance	Drug	N/A	
167603	Stivarga	Drug	N/A	
167603	Nublexa	Drug	N/A	
167602	Ravulizumab	Drug	N/A	
167602	Ultomiris	Drug	N/A	
167602	ravulizumab-cwvz	Drug	N/A	
167601	Ramucirumab	Drug	N/A	
167601	Cyramza	Drug	N/A	
167600	Radium chloride RA-223	Drug	N/A	
167600	Alpharadin	Drug	N/A	
167600	Xofigo	Drug	N/A	
167599	Gavreto	Drug	N/A	
167599	Pralsetinib	Drug	N/A	
167598	Folotyn	Drug	N/A	
167598	Pralatrexate	Drug	N/A	
167597	Iclusig	Drug	N/A	
167597	Ponatinib	Drug	N/A	
167596	3-amino-thalidomide	Drug	N/A	
167596	Pomalid	Drug	N/A	
167596	Pomalidomide	Drug	N/A	
167596	Ibipolid	Drug	N/A	
167596	Imnovid	Drug	N/A	
167596	Actimid	Drug	N/A	
167596	Pomalyst	Drug	N/A	
167595	Polatuzumab vedotin-piiq	Drug	N/A	
167595	Polatuzumab vedotin	Drug	N/A	
167595	Polivy	Drug	N/A	
167594	Phesgo	Drug	N/A	
167594	Hyaluronidase / pertuzumab / trastuzumab	Drug	N/A	
167593	Perjeta	Drug	N/A	
167593	Omnitarg	Drug	N/A	
167593	Pertuzumab	Drug	N/A	
167592	Turalio	Drug	N/A	
167592	Pexidartinib	Drug	N/A	
167591	Pemigatinib	Drug	N/A	
167591	Pemazyre	Drug	N/A	
167590	Pembrolizumab	Drug	N/A	
167590	Keytruda	Drug	N/A	
167590	Lambrolizumab	Drug	N/A	
167589	Pazopanib	Drug	N/A	
167589	Votrient	Drug	N/A	
167589	Pazopater	Drug	N/A	
167588	Panobinostat lactate anhydrous	Drug	N/A	
167588	Farydak	Drug	N/A	
167588	Faridak	Drug	N/A	
167588	Panobinostat	Drug	N/A	
167587	Panitumumab	Drug	N/A	
167587	Vectibix	Drug	N/A	
167586	Pacritinib	Drug	N/A	
167586	Vonjo	Drug	N/A	
167585	Osimert	Drug	N/A	
167585	Osimertinib	Drug	N/A	
167585	Tagrisso	Drug	N/A	
167585	Tagrix	Drug	N/A	
167584	Synribo	Drug	N/A	
167584	Omapro	Drug	N/A	
167584	Omacetaxine mepesuccinate	Drug	N/A	
167583	Olaparix	Drug	N/A	
167583	Olanib	Drug	N/A	
167583	Lynparza	Drug	N/A	
167583	Olaparib	Drug	N/A	
167582	Afutuzumab	Drug	N/A	
167582	Gazyva	Drug	N/A	
167582	Obinutuzumab	Drug	N/A	
167581	Nivolumab / relatlimab	Drug	N/A	
167581	Opdualag	Drug	N/A	
167580	Nivolumab	Drug	N/A	
167580	Opdivo	Drug	N/A	
167579	Zejula	Drug	N/A	
167579	Niranib	Drug	N/A	
167579	Niraparib	Drug	N/A	
167578	Ofev	Drug	N/A	
167578	Nintenib	Drug	N/A	
167578	Idofnib	Drug	N/A	
167578	Nifev	Drug	N/A	
167578	Nintena	Drug	N/A	
167578	Nintib	Drug	N/A	
167578	Vargatef	Drug	N/A	
167578	Nindanib	Drug	N/A	
167578	Nintedanib	Drug	N/A	
167578	Cyendiv	Drug	N/A	
167577	Neratinib	Drug	N/A	
167577	Nerlynx	Drug	N/A	
167576	Ebola Sudan virus disease	Diagnosis	N/A	
167576	Ebola infection, Sudan virus	Diagnosis	N/A	
167575	Necitumumab	Drug	N/A	
167575	Portrazza	Drug	N/A	
167574	Danyelza	Drug	N/A	
167574	Naxitamab-gqgk	Drug	N/A	
167574	Naxitamab	Drug	N/A	
167573	Moxetumomab pasudotox	Drug	N/A	
167573	Lumoxiti	Drug	N/A	
167573	Moxetumomab pasudotox-tdfk	Drug	N/A	
167572	Mogamulizumab-kpkc	Drug	N/A	
167572	Mogamulizumab	Drug	N/A	
167572	Poteligeo	Drug	N/A	
167571	Exkivity	Drug	N/A	
167571	Mobocertinib	Drug	N/A	
167570	Tauritmo	Drug	N/A	
167570	Midostaurin	Drug	N/A	
167570	Rydapt	Drug	N/A	
167569	Mepolizumab	Drug	N/A	
167569	Nucala	Drug	N/A	
167568	Margetuximab	Drug	N/A	
167568	Margenza	Drug	N/A	
167568	Margetuximab-cmkb	Drug	N/A	
167567	Pluvicto	Drug	N/A	
167567	Lutetium Lu 177 vipivotide tetraxetan	Drug	N/A	
167566	Lutathera	Drug	N/A	
167566	Lutetium Lu 177 dotatate	Drug	N/A	
167565	Zepzelca	Drug	N/A	
167565	Lurbinectedin	Drug	N/A	
167564	Lorlatinib	Drug	N/A	
167564	Lorbrena	Drug	N/A	
167563	Loncastuximab tesirine-lpyl	Drug	N/A	
167563	Zynlonta	Drug	N/A	
167563	Loncastuximab tesirine	Drug	N/A	
167562	Lisocabtagene maraleucel	Drug	N/A	
167562	Liso-cel	Drug	N/A	
167562	Breyanzi	Drug	N/A	
167561	Levoleucovorin	Drug	N/A	
167561	Fusilev	Drug	N/A	
167561	Khapzory	Drug	N/A	
167560	Lenvatinib	Drug	N/A	
167560	Lenvima	Drug	N/A	
167559	Larotrectinib	Drug	N/A	
167559	Vitrakvi	Drug	N/A	
167558	Herlapsa	Drug	N/A	
167558	Abnib	Drug	N/A	
167558	Hertab	Drug	N/A	
167558	Lapanix	Drug	N/A	
167558	Combinib	Drug	N/A	
167558	Lapatem	Drug	N/A	
167558	Etibo	Drug	N/A	
167558	Tykerb	Drug	N/A	
167558	Herduo	Drug	N/A	
167558	Lapatinib	Drug	N/A	
167558	Tyverb	Drug	N/A	
167557	Ixazomib	Drug	N/A	
167557	Ninlaro	Drug	N/A	
167556	Ivosidenib	Drug	N/A	
167556	Tibsovo	Drug	N/A	
167555	Isatuximab	Drug	N/A	
167555	Sarclisa	Drug	N/A	
167554	Interpretation of major crossmatch results	Test	Text	
167553	Irinotecan liposomal	Drug	N/A	
167553	Onivyde	Drug	N/A	
167553	Irinotecan liposome	Drug	N/A	
167552	Ipilimumab	Drug	N/A	
167552	Yervoy	Drug	N/A	
167551	Besponsa	Drug	N/A	
167551	Inotuzumab ozogamicin	Drug	N/A	
167550	Infigratinib	Drug	N/A	
167550	Truseltiq	Drug	N/A	
167549	Idecabtagene vicleucel	Drug	N/A	
167549	Abecma	Drug	N/A	
167548	Ibrutinib	Drug	N/A	
167548	Lucibru	Drug	N/A	
167548	Ibrutix	Drug	N/A	
167548	Ibrunib	Drug	N/A	
167548	Imbruvica	Drug	N/A	
167547	Glasdegib	Drug	N/A	
167547	Daurismo	Drug	N/A	
167546	Gilteritinib	Drug	N/A	
167546	Xospata	Drug	N/A	
167545	Gemtuzumab ozogamicin	Drug	N/A	
167545	Mylotarg	Drug	N/A	
167544	Locametz	Drug	N/A	
167544	Gallium ga-68 gozetotide	Drug	N/A	
167543	Lytgobi	Drug	N/A	
167543	Futibatinib	Drug	N/A	
167542	Tavalisse	Drug	N/A	
167542	Fostamatinib	Drug	N/A	
167541	Fedratinib	Drug	N/A	
167541	Inrebic	Drug	N/A	
167540	Trastuzumab deruxtecan	Drug	N/A	
167540	Enhertu	Drug	N/A	
167539	Eltrom	Drug	N/A	
167539	Eltrombopag	Drug	N/A	
167539	Revolade	Drug	N/A	
167539	Promacta	Drug	N/A

akanter · November 10, 2022, 3:09pm

New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for November 4, 2022!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.11.4, 2.0.1, 2.1, 2.2, 2.3, 2.4 and 2.5. Note that I will no longer be releasing in versions prior to 1.11

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL.

https://app.openconceptlab.org/#/orgs/CIEL/

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release includes new concepts for Oncology (drug ingredients) and new concepts for MSF, the new Kenya HDD/KenyaEMR including reasons for COVID vaccine rejection and new COVID-19 variants. The COVID-19 starter collection was also updated.

It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.

The drug table was not updated for this release. We are working on getting a new version of the drug table out, but if you are interested, reach out to me separately.

concept_id	name	Class	Datatype	description
167715	Class of psychotropic medication initiated	Question	Coded	
167714	Ligament of pelvic girdle	Anatomy	N/A	
167714	Ligament of pelvis	Anatomy	N/A	
167713	Sofosbuvir / Daclatasvir	Drug	N/A	
167713	Daclatasvir / Sofosbuvir	Drug	N/A	
167713	Sovodak	Drug	N/A	
167712	Prior drug treatment program participation	Question	Coded	
167711	&gt; 1 yr	Misc	N/A	
167711	Greater than one year	Misc	N/A	
167711	> 1 yr	Misc	N/A	
167710	&lt; 1 yr	Misc	N/A	
167710	Less than one year	Misc	N/A	
167710	< 1 yr	Misc	N/A	
167709	One year	Misc	N/A	
167709	1 yr	Misc	N/A	
167708	Positive COVID-19 protocol	Question	Coded	
167708	Positive SARS-CoV-2 protocol	Question	Coded	
167707	United Nations Relief and Works Agency for Palestine Refugees in the Near East	Misc	N/A	
167707	UNRWA	Misc	N/A	
167706	Médecins Sans Frontières West and Central Africa	Misc	N/A	
167706	MSF WaCA	Misc	N/A	
167705	Médecins Sans Frontières Paris	Misc	N/A	
167705	MSF OCP	Misc	N/A	
167704	MSF OCBA	Misc	N/A	
167704	Médecins Sans Frontières Barcelona-Athens	Misc	N/A	
167703	Médecins Sans Frontières Geneva	Misc	N/A	
167703	M&eacute;decins Sans Fronti&egrave;res Geneva	Misc	N/A	
167703	MSF OCG	Misc	N/A	
167703	Médecins Sans Frontières Geneva	Misc	N/A	
167702	Médecins Sans Frontières Brussels	Misc	N/A	
167702	M&eacute;decins Sans Fronti&egrave;res Brussels	Misc	N/A	
167702	Médecins Sans Frontières Brussels	Misc	N/A	
167702	MSF OCB	Misc	N/A	
167701	Delusion that vaccine is combined with contraceptive	Finding	N/A	
167700	Delusion that vaccines will kill them	Finding	N/A	
167699	Delusion that antiretrovirals can cure/prevent COVID-19	Finding	N/A	
167698	Delusion that vaccine replicates DNA	Finding	N/A	
167698	Delusion that vaccine replicates one&amp;#39;s DNA	Finding	N/A	
167698	Delusion that vaccine replicates one&#39;s DNA	Finding	N/A	
167698	Delusion that vaccine replicates one's DNA	Finding	N/A	
167697	Concerned about safety in immunocompromised people	Finding	N/A	For example, in PLHIV or HIV-infected people
167696	Individual therapy	Procedure	N/A	
167696	Individual psychotherapy	Procedure	N/A	
167695	Group therapy	Procedure	N/A	
167695	Group psychotherapy	Procedure	N/A	
167694	Session type	Question	Coded	The type of therapy session attended
167693	Session attended	ConvSet	N/A	
167692	Isoniazid / Rifapentine	Drug	N/A	Fixed combination medication with INH and Rifapentine
167691	Detained by authorities	Finding	N/A	
167690	Significant change in social role/position	Finding	N/A	
167689	Witness to violence	Finding	N/A	
167688	Sickness in family	Finding	N/A	
167688	Relative/family member sick	Finding	N/A	
167687	Loss of relative/family member	Finding	N/A	Relative or family member has died, been detained, is missing, etc.
167686	Relational problem with family member	Finding	N/A	
167685	Non-governmental organisation	Misc	N/A	
167685	Non-governmental organization	Misc	N/A	
167685	Non-governmental organization	Misc	N/A	
167685	Nongovernmental organization	Misc	N/A	
167685	NGO	Misc	N/A	
167684	Sofobuvir / velpatasvir	Drug	N/A	
167684	Sofosbuvir / velpatasvir	Drug	N/A	
167684	Epclusa	Drug	N/A	
167683	Aware of conditions that could lead to involuntary discharge from Medically Assisted Therapy (MAT)	Question	Coded	
167682	History of complications related to injecting drug use	Question	Coded	
167682	History of complications related to intravenous drug use	Question	Coded	
167681	IVDU reason	Question	Coded	
167681	Reason for using intravenous drugs	Question	Coded	
167680	Theft/Property damage of clinic/instituation	Finding	N/A	
167679	Diversion of buprenorphine	Finding	N/A	
167679	Stealing buprenorphine	Finding	N/A	
167678	Diversion of methadone	Finding	N/A	
167678	Stealing methadone	Finding	N/A	
167677	Wearing guns/weapons	Finding	N/A	
167677	Weapons possession	Finding	N/A	
167676	Delusion about being immune to disease	Finding	N/A	
167675	Fear of drug class interaction with vaccine	Question	Coded	
167674	Media-induced fear of vaccination	Finding	N/A	
167674	Media-induced fear of immunization	Finding	N/A	
167673	Insufficient vaccine testing/study	Finding	N/A	
167673	Concerned about insufficient vaccine testing/study	Finding	N/A	
167673	Insufficient vaccine testing/study	Finding	N/A	
167672	Flashblood user	Question	Coded	
167672	Flushblood user	Question	Coded	
167671	Number of missed appointments	Question	Numeric	
167670	Involuntary discharge from program	Procedure	N/A	
167669	Reason for no show	Question	Coded	
167669	Reason for defaulting	Question	Coded	
167668	Date enrolled in substance abuse program	Question	Datetime	
167667	Court system	Misc	N/A	
167667	Criminal justice system	Misc	N/A	
167666	Previous referral for Medically Assisted Therapy (MAT) services	Question	Coded	
167665	Recommended for immediate enrollment for Medically Assisted Therapy (MAT)	Question	Coded	
167664	Ceritinib	Drug	N/A	
167664	Zykadia	Drug	N/A	
167664	Lucicer	Drug	N/A	
167664	Spexib	Drug	N/A	
167664	Noxalk	Drug	N/A	
167663	Libtayo	Drug	N/A	
167663	Cemiplimab	Drug	N/A	
167662	Carfilnat	Drug	N/A	
167662	Carfilzomib	Drug	N/A	
167662	Kyprolis	Drug	N/A	
167661	Mannerisms	Finding	N/A	
167660	Zirabev	Drug	N/A	
167660	Bevacizumab-bvzr	Drug	N/A	
167659	Mvasi	Drug	N/A	
167659	Bevacizumab-awwb	Drug	N/A	
167658	Bevacizumab-adcd	Drug	N/A	
167658	Vegzelga	Drug	N/A	
167657	Fasenra	Drug	N/A	
167657	Benralizumab	Drug	N/A	
167656	In good standing	Misc	N/A	Program status where patient/enrollee is still enrolled and in good standing.
167655	Cost of vaccination	Misc	N/A	Potential reason for not receiving care
167655	Cost of immunization	Misc	N/A	Potential reason for not receiving care
167654	Delay time for results	Misc	N/A	
167654	Waiting time for results	Misc	N/A	
167653	Wait time for procedure	Misc	N/A	
167653	Delay time for procedure	Misc	N/A	
167653	Wait time	Misc	N/A	
167653	Delay time	Misc	N/A	
167652	Vaccine-related death	Finding	N/A	
167652	Death due to immunization	Finding	N/A	
167652	Death due to vaccination	Finding	N/A	
167651	At risk for clots	Finding	N/A	
167651	At risk of venous thromboembolism	Finding	N/A	
167650	Type of fear regarding vaccination	Question	Coded	
167650	Fears about vaccination	Question	Coded	
167649	XBB variant	Misc	N/A	SARS-CoV-2 (COVID-19) virus variant
167648	BQ.1.1 variant	Misc	N/A	SARS-CoV-2 (COVID-19) virus variant
167647	Zaltrap	Drug	N/A	
167647	Ziv-aflibercept	Drug	N/A	
167646	Brukinsa	Drug	N/A	
167646	Zanubrutinib	Drug	N/A	
167645	Voxelotor	Drug	N/A	
167645	Oxbryta	Drug	N/A	
167644	Vorinostat	Drug	N/A	
167644	Zolinza	Drug	N/A	
167643	Erivedge	Drug	N/A	
167643	Vismodegib	Drug	N/A	
167642	Javlor	Drug	N/A	
167642	Vinflunine	Drug	N/A	
167641	Vincristine liposomal	Drug	N/A	
167641	Vincristine liposome	Drug	N/A	
167641	Marqibo	Drug	N/A	
167640	Venclexta	Drug	N/A	
167640	Venetoclax	Drug	N/A	
167639	Vemurafenib	Drug	N/A	
167639	Zelboraf	Drug	N/A	
167638	Caprelsa	Drug	N/A	
167638	Zactima	Drug	N/A	
167638	Lucivand	Drug	N/A	
167638	Vandetanib	Drug	N/A	
167637	Ukoniq	Drug	N/A	
167637	Umbralisib	Drug	N/A	
167636	Tucatinib	Drug	N/A	
167636	Irbinitinib	Drug	N/A	
167636	Tukysa	Drug	N/A	
167635	trastuzumab-oysk and hyaluronidase-oysk	Drug	N/A	
167635	Herceptin hylecta	Drug	N/A	
167635	Hyaluronidase / trastuzumab	Drug	N/A	
167634	Trastuzumab-qyyp	Drug	N/A	
167634	Trazimera	Drug	N/A	
167633	Herzuma	Drug	N/A	
167633	Trastuzumab-pkrb	Drug	N/A	
167632	Ontruzant	Drug	N/A	
167632	Trastuzumab-dttb	Drug	N/A	
167631	Ogivri	Drug	N/A	
167631	Trastuzumab-dkst	Drug	N/A	
167630	Kanjinti	Drug	N/A	
167630	Trastuzumab-anns	Drug	N/A	
167629	Mekinist	Drug	N/A	
167629	Trametinib	Drug	N/A	
167629	Meqsel	Drug	N/A	
167628	Trabectedin	Drug	N/A	
167628	Yondelis	Drug	N/A	
167627	Kymriah	Drug	N/A	
167627	Tisagenlecleucel	Drug	N/A	
167626	Tepmetko	Drug	N/A	
167626	Tepotinib	Drug	N/A	
167625	Telotristat ethyl	Drug	N/A	
167625	Xermelo	Drug	N/A	
167624	Tazemetostat	Drug	N/A	
167624	Tazverik	Drug	N/A	
167623	Talzenna	Drug	N/A	
167623	Talazoparib	Drug	N/A	
167622	Tagraxofusp	Drug	N/A	
167622	Elzonris	Drug	N/A	
167622	Tagraxofusp-erzs	Drug	N/A	
167621	Tafasitamab-cxix	Drug	N/A	
167621	Monjuvi	Drug	N/A	
167621	Tafasitamab	Drug	N/A	
167620	Sotorasib	Drug	N/A	
167620	Lumakras	Drug	N/A

akanter · December 22, 2022, 10:07pm

New version of CIEL dictionary added to dropbox AND soon to be updated on Open Concept Lab for December 21, 2022!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.11.4, 2.0.1, 2.1, 2.2, 2.3, 2.4 and 2.5. Note that I will no longer be releasing in versions prior to 1.11

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL.

https://app.openconceptlab.org/#/orgs/CIEL/

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release includes new concepts for Oncology (drug ingredients) and new concepts for MSF, the new Kenya HDD/KenyaEMR, coded HIV ART regimens, and updated normal ranges for vitals for OMRS 3.0 .

It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.

The drug table was not updated for this release. We are working on getting a new version of the drug table out, but if you are interested, reach out to me separately.

|concept_id|name|Class|Datatype|description|
|---|---|---|---|---|
|167825|Severe pregnancy-induced hypertension|Diagnosis|N/A||
|167825|Severe gestational hypertension|Diagnosis|N/A||
|167824|Host|Misc|N/A|A person living within a host community which is hosting internally displaced persons (IDPs) in the homes of community members and/or in spontaneous or formal camps nearby.|
|167823|Legal status|Question|Coded||
|167822|Occupational exposure to risk factor|Finding|N/A||
|167822|Occupational exposure|Finding|N/A||
|167821|Number of disease exacerbations|Question|Numeric||
|167820|Number of disease exacerbations construct|ConvSet|N/A||
|167819|Missed medication doses in past seven days|Question|Coded||
|167819|Missed medication doses in seven days|Question|Coded||
|167819|Missed medication doses in last week|Question|Coded||
|167819|Number of missed medication doses in seven days|Question|Coded||
|167819|Number of missed medication doses in last week|Question|Coded||
|167818|Last date of discharge from hospital|Question|Date||
|167818|Most recent date of discharge from hospital|Question|Date||
|167817|Hypoglycemic event since last visit|Question|Coded|Whether the patient has experienced a hypoglycemic event since the last visit.|
|167817|Hypoglycaemia since last visit|Question|Coded|Whether the patient has experienced a hypoglycemic event since the last visit.|
|167816|Previous mental health treatment|Question|Coded|What mental health care and services the patient had previously received.|
|167816|History of mental health treatment|Question|Coded|What mental health care and services the patient had previously received.|
|167815|Protective services|Misc|N/A||
|167815|Protection services|Misc|N/A||
|167814|Legal services|Misc|N/A||
|167813|SRH|Misc|N/A||
|167813|Sexual/reproductive health service|Misc|N/A||
|167812|Instructions|Procedure|Coded||
|167812|Recommendations to clinician/department|Procedure|Coded||
|167811|Vaginal cancer|Diagnosis|N/A||
|167811|Malignant neoplasm of vagina|Diagnosis|N/A||
|167810|HCV Ag|Test|Coded||
|167810|Hepatitis C viral antigen measurement|Test|Coded||
|167809|Patient education|Procedure|N/A||
|167808|24 weeks|Misc|N/A|Generic answer to a question.|
|167808|Twenty-four weeks|Misc|N/A|Generic answer to a question.|
|167807|Twelve weeks|Misc|N/A|Generic answer to a question|
|167807|12 weeks|Misc|N/A|Generic answer to a question|
|167806|Very much worse|Misc|N/A|Severe exacerbation of symptoms and loss of functioning|
|167805|Much worse|Misc|N/A|Clinically significant increase in symptoms and diminished functioning|
|167804|Minimally worse|Misc|N/A|Slightly worse but may not be clinically meaningful; may represent very little change in basic clinical status or functional capacity|
|167803|Minimally improved|Finding|N/A|Slightly better with little or no clinically meaningful reduction of symptoms. Represents very little change in basic clinical status, level of care, or functional capacity|
|167802|Much improved|Finding|N/A|Notably better with significant reduction of symptoms; increase in the level of functioning but some symptoms remain|
|167801|Very much improved|Finding|N/A|Nearly all better; good level of functioning; minimal symptoms; represents a very substantial change|
|167800|Clinical Global Impression Severity Set|ConvSet|N/A||
|167800|CGI-S set|ConvSet|N/A||
|167799|Extremely ill|Finding|N/A|Among the most extremely ill patients&amp;mdash;pathology drastically interferes in many life functions; may be hospitalized|
|167798|Severely ill|Finding|N/A|Disruptive pathology, behavior and function are frequently influenced by symptoms, may require assistance from others|
|167797|Markedly ill|Finding|N/A|Intrusive symptoms that distinctly impair social/occupational function or cause intrusive levels of distress|
|167796|Moderately ill|Finding|N/A|Overt symptoms causing noticeable, but modest, functional impairment or distress; symptom level may warrant medication|
|167795|Mildly ill|Finding|N/A|Clearly established symptoms with minimal, if any, distress or difficulty in social and occupational function|
|167794|Borderline ill|Finding|N/A|Subtle or suspected pathology|
|167793|Sofosbuvir / Velpatasvir / Voxilaprevir|Drug|N/A||
|167793|Vosevi|Drug|N/A||
|167792|DRV/r+ABC+EFV+3TC child regimen|Misc|N/A||
|167792|Abacavir / Darunavir / Efavirenz / Lamivudine / Ritonavir child regimen|Misc|N/A||
|167792|6G - DRV/r+ABC+3TC+EFV child|Misc|N/A||
|167791|6F - DRV/r+DTG+ABC+3TC child|Misc|N/A||
|167791|Abacavir / Darunavir / Dolutegravir / Lamivudine / Ritonavir child regimen|Misc|N/A||
|167791|DRV/r+ABC+3TC+DTG child regimen|Misc|N/A||
|167790|Antiretroviral treatment started|Question|Coded||
|167790|ARV treatment started|Question|Coded||
|167790|ART started|Question|Coded||
|167789|Case confirmed bacteriologically|Question|Coded||
|167789|Diagnosis confirmed bacteriologically|Question|Coded||
|167788|Reason for visit (coded)|Question|Coded||
|167787|hepatitis C virus RNA viral load by probe and target amplification method (IU/ml)|Test|Numeric||
|167787|Hepatitis C virus RNA PCR quantitative (IU/ml)|Test|Numeric||
|167787|HCV RNA PCR quantitative (IU/ml)|Test|Numeric||
|167787|HCV PCR quant|Test|Numeric||
|167786|HCV PCR qualitative|Test|Coded||
|167786|Hepatitis C virus (HCV) nucleic acid detection by PCR in serum/plasma|Test|Coded||
|167785|HBV e Ag|Test|Coded|Presence of Hepatitis B viral e antigen in serum/plasma|
|167785|Hepatitis B virus e antigen assay|Test|Coded|Presence of Hepatitis B viral e antigen in serum/plasma|
|167784|Was procedure performed/carried out|Question|Coded||
|167783|Willing to participate in methadone maintenance treatment|Question|Coded||
|167782|6H - DRV/r+AZT+3TC+EFV child|Misc|N/A||
|167782|Darunavir / Efavirenz / Lamivudine / Ritonavir / Zidovudine child regimen|Misc|N/A||
|167782|3TC/AZT/EFV/DRV/r child regimen|Misc|N/A||
|167781|Darunavir / Efavirenz / Lamivudine / Ritonavir / Zidovudine adult regimen|Misc|N/A||
|167781|3F - DRV/r+AZT+3TC+EFV adult|Misc|N/A||
|167781|3TC/AZT/EFV/DRV/r adult regimen|Misc|N/A||
|167780|Darunavir / Dolutegravir / Lamivudine / Ritonavir / Tenofovir child regimen|Misc|N/A||
|167780|3TC/DRV/DTG/RTV/TDF child regimen|Misc|N/A||
|167780|6D - DRVr+DTG+TDF+3TC child|Misc|N/A||
|167779|6C - DRVr+DTG+AZT+3TC child|Misc|N/A||
|167779|Darunavir / Dolutegravir / Lamivudine / Ritonavir / Zidovudine child regimen|Misc|N/A||
|167778|3E - DRV/r+TDF+3TC+EFV adult|Misc|N/A||
|167778|Darunavir / Efavirenz / Lamivudine / Ritonavir / Tenofovir adult regimen|Misc|N/A||
|167778|DRV/r+TDF+3TC+EFV adult regimen|Misc|N/A||
|167777|DRV/r+ABC+3TC+DTG adult regimen|Misc|N/A||
|167777|3C - DRV/r+ABC+3TC+DTG adult|Misc|N/A||
|167777|Abacavir / Darunavir / Dolutegravir / Lamivudine / Ritonavir adult regimen|Misc|N/A||
|167776|3B - DRVr+DTG+TDF/3TC adult|Misc|N/A||
|167776|3TC/DRV/DTG/RTV/TDF adult regimen|Misc|N/A||
|167776|Darunavir / Dolutegravir / Lamivudine / Ritonavir / Tenofovir adult regimen|Misc|N/A||
|167775|3A - DRVr+DTG+AZT/3TC adult regimen|Misc|N/A||
|167775|Darunavir / Dolutegravir / Lamivudine / Ritonavir / Zidovudine adult regimen|Misc|N/A||
|167774|3TC/ABC/RAL child regimen|Misc|N/A||
|167774|Abacavir / Lamivudine / Raltegravir child regimen|Misc|N/A||
|167774|5L - RAL+ABC+3TC child|Misc|N/A||
|167773|Lamivudine / Raltegravir / Zidovudine child regimen|Misc|N/A||
|167773|3TC/AZT/RAL child regimen|Misc|N/A||
|167773|5K - RAL+AZT+3TC child|Misc|N/A||
|167772|3TC/ABC/LPV/r adult regimen|Misc|N/A||
|167772|Abacavir / Lamivudine / Lopinavir / Ritonavir adult regimen|Misc|N/A||
|167772|2I - ABC+3TC+LPVr adult|Misc|N/A||
|167771|2H - TDF+3TC+ATVr adult|Misc|N/A||
|167771|Atazanavir / Lamivudine / Ritonavir / Tenofovir adult regimen|Misc|N/A||
|167771|TDF/3TC/ATV/r adult regimen|Misc|N/A||
|167770|5I - TDF+3TC+LPVr child|Misc|N/A||
|167770|Lamivudine / Lopinavir / Ritonavir / Tenofovir child regimen|Misc|N/A||
|167770|3TC/LPV/r/TDF child regimen|Misc|N/A||
|167769|2G - TDF+3TC+LPVr adult|Misc|N/A||
|167769|Lamivudine / Lopinavir / Ritonavir / Tenofovir adult regimen|Misc|N/A||
|167769|3TC/LPV/r/TDF adult regimen|Misc|N/A||
|167768|2F - AZT+3TC+ATVr adult|Misc|N/A||
|167768|AZT-3TC-ATV/r adult regimen|Misc|N/A||
|167768|Atazanavir / Lamivudine / Ritonavir / Zidovudine adult regimen|Misc|N/A||
|167767|Lamivudine / Lopinavir / Ritonavir / Zidovudine adult regimen|Misc|N/A||
|167767|3TC/AZT/LPV/r adult regimen|Misc|N/A||
|167767|2E - AZT+3TC+LPVr adult|Misc|N/A||
|167766|TDF/DDI/NFV child regimen|Misc|N/A||
|167766|Didanosine / Nelfinavir / Tenofovir child regiment|Misc|N/A||
|167766|5D - TDF+DDI+NFV child|Misc|N/A||
|167765|TDF/DDI/NFV adult regimen|Misc|N/A||
|167765|2D - TDF+DDI+NFV adult|Misc|N/A||
|167765|Didanosine / Nelfinavir / Tenofovir adult regiment|Misc|N/A||
|167764|5C - TDF+DDI+LPV child|Misc|N/A||
|167764|DDI/LPV/TDF child regimen|Misc|N/A||
|167764|Didanosine / Lopinavir / Tenofovir child regimen|Misc|N/A||
|167763|2C - TDF+DDI+LPV adult|Misc|N/A||
|167763|Didanosine / Lopinavir / Tenofovir adult regimen|Misc|N/A||
|167763|2C - TDF+DDI+LPV|Misc|N/A||
|167763|DDI/LPV/TDF adult regimen|Misc|N/A||
|167762|5B - ABC+DDI+NFV child|Misc|N/A||
|167762|Abacavir / Didanosine / Nelfinavir child regimen|Misc|N/A||
|167762|ABC/DDI/NFV child regimen|Misc|N/A||
|167762|5B - ABC+DDL+NFV child|Misc|N/A||
|167761|2B - ABC+DDI+NFV adult|Misc|N/A||
|167761|2B - ABC+DDL+NFV adult|Misc|N/A||
|167761|Abacavir / Didanosine / Nelfinavir adult regimen|Misc|N/A||
|167761|ABC/DDI/NFV adult regimen|Misc|N/A||
|167760|5A - ABC+DDI+LPV child|Misc|N/A||
|167760|Abacavir / Didanosine / Lopinavir child regimen|Misc|N/A||
|167760|ABC/DDI/LPV child regimen|Misc|N/A||
|167759|Abacavir / Didanosine / Lopinavir adult regimen|Misc|N/A||
|167759|2A - ABC+DDI+LPV adult|Misc|N/A||
|167759|ABC/DDI/LPV adult regimen|Misc|N/A||
|167758|Efavirenz / Lamivudine / Stavudine 40 mg child regimen|Misc|N/A||
|167758|d4T(40)/3TC/EFV child regimen|Misc|N/A||
|167758|1B40 - D4T(40)+3TC+EFV|Misc|N/A||
|167757|Efavirenz / Lamivudine / Stavudine 30 mg child regimen|Misc|N/A||
|167757|1B30 - D4T(30)+3TC+EFV|Misc|N/A||
|167757|d4T(30)/3TC/EFV child regimen|Misc|N/A||
|167756|5M - ABC+3TC+DTG child|Misc|N/A||
|167756|Abacavir / Dolutegravir / Lamivudine child regimen|Misc|N/A||
|167756|4J - ABC+3TC+DTG child|Misc|N/A||
|167756|ABC/3TC/DTG child regimen|Misc|N/A||
|167755|5E - ABC+3TC+LPVr child|Misc|N/A||
|167755|3TC/ABC/LPV/r child regimen|Misc|N/A||
|167755|4G - ABC+3TC+LPVr child|Misc|N/A||
|167755|Abacavir / Lamivudine / Lopinavir / Ritonavir child regimen|Misc|N/A||
|167754|5F - AZT+3TC+LPVr child|Misc|N/A||
|167754|4F - AZT+3TC+LPVr child|Misc|N/A||
|167754|Lamivudine / Lopinavir / Ritonavir / Zidovudine child regimen|Misc|N/A||
|167754|3TC/AZT/LPV/r child regimen|Misc|N/A||
|167753|d4T/3TC/EFV child regimen|Misc|N/A||
|167753|4B - D4T+3TC+EFV child|Misc|N/A||
|167753|Efavirenz / Lamivudine / Stavudine child regimen|Misc|N/A||
|167752|Lamivudine / Nevirapine / Stavudine child regimen|Misc|N/A||
|167752|4A - D4T+3TC+NVP child|Misc|N/A||
|167752|d4T/3TC/NVP child regimen|Misc|N/A||
|167751|5N - AZT+3TC+DTG child|Misc|N/A||
|167751|DTG/3TC/AZT child regimen|Misc|N/A||
|167751|Dolutegravir / Lamivudine / Zidovudine child regimen|Misc|N/A||
|167751|4K - AZT+3TC+DTG child|Misc|N/A||
|167750|2K - AZT+3TC+DTG adult|Misc|N/A||
|167750|1K - AZT+3TC+DTG adult|Misc|N/A||
|167750|DTG/3TC/AZT adult regimen|Misc|N/A||
|167750|Dolutegravir / Lamivudine / Zidovudine adult regimen|Misc|N/A||
|167749|5O - TDF+3TC+DTG child|Misc|N/A||
|167749|Dolutegravir / Lamivudine / Tenofovir child regimen|Misc|N/A||
|167749|TDF/3TC/DTG child regimen|Misc|N/A||
|167749|4I - TDF+3TC+DTG child|Misc|N/A||
|167748|2J - TDF+3TC+DTG adult|Misc|N/A||
|167748|Dolutegravir / Lamivudine / Tenofovir adult regimen|Misc|N/A||
|167748|1J - TDF+3TC+DTG adult|Misc|N/A||
|167748|TDF/3TC/DTG adult regimen|Misc|N/A||
|167747|ABC/NVP/3TC adult regimen|Misc|N/A||
|167747|Abacavir / Nevirapine / Lamivudine adult regimen|Misc|N/A||
|167747|1H - ABC+3TC+NVP adult|Misc|N/A||
|167746|1F - TDF+3TC+NVP adult|Misc|N/A||
|167746|3TC/NVP/TDF adult regimen|Misc|N/A||
|167746|Lamivudine / Nevirapine / Tenofovir adult regimen|Misc|N/A||
|167745|5G - TDF+3TC+EFV child|Misc|N/A||
|167745|4E - TDF+3TC+EFV child|Misc|N/A||
|167745|3TC/EFV/TDF child regimen|Misc|N/A||
|167745|Lamivudine / Efavirenz / Tenofovir child regimen|Misc|N/A||
|167744|3TC/EFV/TDF adult regimen|Misc|N/A||
|167744|1E - TDF+3TC+EFV adult|Misc|N/A||
|167744|Lamivudine / Efavirenz / Tenofovir adult regimen|Misc|N/A||
|167743|3TC/AZT/EFV child regimen|Misc|N/A||
|167743|4D - AZT+3TC+EFV child|Misc|N/A||
|167743|Efavirenz / Lamivudine / Zidovudine child regimen|Misc|N/A||
|167742|Efavirenz / Lamivudine / Zidovudine adult regimen|Misc|N/A||
|167742|3TC/AZT/EFV adult regimen|Misc|N/A||
|167742|1D - AZT+3TC+EFV adult|Misc|N/A||
|167741|4C - AZT+3TC+NVP child|Misc|N/A||
|167741|Lamivudine / nevirapine / zidovudine child regimen|Misc|N/A||
|167741|3TC/AZT/NVP child regimen|Misc|N/A||
|167740|3TC/AZT/NVP adult regimen|Misc|N/A||
|167740|Lamivudine / nevirapine / zidovudine adult regimen|Misc|N/A||
|167740|1C - AZT+3TC+NVP adult|Misc|N/A||
|167739|5H - ABC+3TC+EFV child|Misc|N/A||
|167739|4L - ABC+3TC+EFV child|Misc|N/A||
|167739|4L - ABC+3TC+EFV|Misc|N/A||
|167739|3TC/ABC/EFV child regimen|Misc|N/A||
|167739|Abacavir / Efavirenz / Lamivudine child regimen|Misc|N/A||
|167738|1G - ABC+3TC+EFV adult|Misc|N/A||
|167738|1g - ABC+3TC+EFV|Misc|N/A||
|167738|1g - ABC+3TC+EFV regimen|Misc|N/A||
|167738|3TC/ABC/EFV adult regimen|Misc|N/A||
|167738|Abacavir / Efavirenz / Lamivudine adult regimen|Misc|N/A||
|167737|Violence condition as stressor|Question|Coded||
|167736|Family condition as stressor|Question|Coded||
|167735|Social condition as stressor|Question|Coded||
|167734|Medical condition as stressor|Question|Coded||
|167733|Follow-up patient|Question|Coded||
|167733|Returning patient|Question|Coded||
|167732|Transfer to other health care facility|Procedure|N/A||
|167731|Internal facility transfer/referral|Procedure|N/A||
|167731|Intra-facility transfer/referral|Procedure|N/A||
|167730|Intentional delayed separation of umbilical cord|Procedure|N/A||
|167730|Delayed cord clamping|Procedure|N/A||
|167730|Delayed separation of umbilical cord|Procedure|N/A||
|167729|Respiratory assessment score|Question|Numeric||
|167728|Silverman-Anderson respiratory assessment|Procedure|N/A||
|167727|Downes respiratory assessment|Procedure|N/A||
|167726|History of administration of maternal corticosteroid administration for fetal lung maturation|Question|Coded||
|167725|Newborn received HIV post-exposure prophylaxis|Question|Coded||
|167724|Radiant warming of newborn|Procedure|N/A||
|167724|Active radiant warming of infant|Procedure|N/A||
|167723|> 6 wks|Misc|N/A||
|167723|> 6 wks|Misc|N/A||
|167723|Greater than 6 weeks|Misc|N/A||
|167722|Six weeks|Misc|N/A||
|167722|6 weeks|Misc|N/A||
|167722|6 wks|Misc|N/A||
|167721|< 6 wks|Misc|N/A||
|167721|< 6 wks|Misc|N/A||
|167721|Less than 6 weeks|Misc|N/A||
|167720|Late-onset neonatal sepsis|Diagnosis|N/A||
|167719|MDA|Misc|N/A|Country in Eastern Europe|
|167719|Republic of Moldova|Misc|N/A|Country in Eastern Europe|
|167718|CD4 count result (qualitative)|Question|Coded||
|167717|CD4 count <=200 cells/uL|Finding|N/A||
|167717|CD4 count <=200 cells/mm3|Finding|N/A||
|167717|CD4 count <=200 cells/uL|Finding|N/A||
|167717|CD4 count less than or equal to 200|Finding|N/A||
|167717|CD4 count <=200 cells/uL|Finding|N/A||
|167716|Sofosbuvir / Velpatasvir + Ribavirin|Misc|N/A|Medication regimen containing three drugs|

sharif · December 26, 2022, 7:03am

Hello @jwnasambu , This is the latest version of CIEL that you should import. Hope you have access to the Dropbox.

jwnasambu · December 26, 2022, 7:06am

@akanter send me the dropbox already and am past the step already. Thanks

akanter · December 28, 2022, 6:15pm

You should already have the link, Juliet. It is always the same…

jwnasambu · December 28, 2022, 6:52pm

Sure! Thanks for the help and follow up.

slubwama · January 6, 2023, 11:19am

@akanter may I access the Drop box folder? Thanks

akanter · January 12, 2023, 8:05pm

Samuel, did you get what you need? If not, please email me directly. Thanks.

slubwama · January 12, 2023, 8:10pm

@akanter it was very helpful. Thanks alot

akanter · January 28, 2023, 4:54pm

New version of CIEL dictionary has been added to dropbox AND updated on Open Concept Lab for January 26, 2022!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.11.4, 2.0.1, 2.1, 2.2, 2.3, 2.4 and 2.5. Note that I will no longer be releasing in versions prior to 1.11

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL.

https://app.openconceptlab.org/#/orgs/CIEL/

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release includes new concepts for FHIR value set support and new concepts for MSF, the new Kenya HDD/KenyaEMR and improved concepts for transsexual gender identity.

It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.

The drug table was not updated for this release. We are working on getting a new version of the drug table out, but if you are interested, reach out to me separately.

COVID-19 Starter Set and MPX collections were also re-released to include new variants and Mpox synonyms.

concept_id	name	Class	Datatype	description
167871	Status of developmental milestones	Question	Coded
167870	Achieved appropriate developmental milestones	Finding	N/A
167869	Identifies as non-binary gender	Finding	N/A
167868	Female to male transsexual	Finding	N/A
167867	Male to female transsexual	Finding	N/A
167866	Identifies as female gender	Finding	N/A
167866	Female	Finding	N/A
167865	Identifies as male gender	Finding	N/A
167865	Male	Finding	N/A
167864	Gender identity	Question	Coded
167863	Antibiotic class	Pharmacologic Drug Class	N/A
167863	Antibacterials	Pharmacologic Drug Class	N/A
167862	SubstanceAdminSubstitutionReason	ConvSet	N/A	REF: <status value="active"/> <experimental value="false"/> <date value="2014-03-26"/> <description value="*No description*"/> <compose> <include> <system value="http://terminology.hl7.org/CodeSystem/v3-ActReason"/> <filter> <property value="concept"/> <op value="is-a"/> <value value="_SubstanceAdminSubstitutionReason"/> </filter> </include> <exclude> <system value="http://terminology.hl7.org/CodeSystem/v3-ActReason"/> <concept> <code value="_SubstanceAdminSubstitutionReason"/> </concept> </exclude> </compose> </ValueSet>
167861	Regulatory requirement	Misc	N/A	Reason for decision. For substitution, indicates that the decision to substitute or to not substitute was driven by a jurisdictional regulatory requirement mandating or prohibiting substitution.
167860	Formulary policy	Misc	N/A	Reason for decision. For substitution, indicates that the decision to substitute or to not substitute was driven by a policy expressed within the formulary.
167859	ActSubstanceAdminSubstitutionCode	ConvSet	N/A	REF: <status value="active"/> <experimental value="false"/> <date value="2014-03-26"/> <description value="*No description*"/> <compose> <include> <system value="http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution"/> <filter> <property value="concept"/> <op value="is-a"/> <value value="_ActSubstanceAdminSubstitutionCode"/> </filter> </include> <exclude> <system value="http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution"/> <concept> <code value="_ActSubstanceAdminSubstitutionCode"/> </concept> </exclude> </compose> </ValueSet>
167858	Formulary substitution	Misc	N/A	This substitution was performed or is permitted based on formulary guidelines.
167858	Formulary	Misc	N/A	This substitution was performed or is permitted based on formulary guidelines.
167857	Therapeutic generic substitution	Misc	N/A	Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands.
167857	Therapeutic generic	Misc	N/A	Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands.
167856	Therapeutic brand substitution	Misc	N/A	Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics.
167856	Therapeutic brand	Misc	N/A	Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics.
167855	Therapeutic alternative substitution	Misc	N/A	Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.
167855	Therapeutic alternative	Misc	N/A	Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.
167854	Generic composition substitution	Misc	N/A
167854	generic composition	Misc	N/A
167853	Brand composition substitution	Misc	N/A	Substitution occurred or is permitted between equivalent Brands but not Generics.
167853	Brand composition	Misc	N/A	Substitution occurred or is permitted between equivalent Brands but not Generics.
167853	Brand composition	Misc	N/A	Substitution occurred or is permitted between equivalent Brands but not Generics.
167852	Equivalent composition substitution	Misc	N/A	Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration.
167852	Equivalent composition	Misc	N/A	Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration.
167852	Equivalent composition	Misc	N/A	Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration.
167851	Equivalent substitution	Misc	N/A	Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.
167851	Equivalent	Misc	N/A	Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.
167851	Equivalent medication	Misc	N/A	Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.
167850	Antimalarials	Pharmacologic Drug Class	N/A
167850	Antimalarial	Pharmacologic Drug Class	N/A
167849	Antiretrovirals	Pharmacologic Drug Class	N/A
167848	CKD, stage 3B	Diagnosis	N/A
167848	Chronic kidney disease, stage IIIB (moderate)	Diagnosis	N/A
167848	Chronic kidney disease, stage 3B (GFR 30-44)	Diagnosis	N/A
167847	CKD, stage 3A	Diagnosis	N/A
167847	Chronic kidney disease, stage 3A (GFR 45-59)	Diagnosis	N/A
167847	Chronic kidney disease, stage 3A (moderate)	Diagnosis	N/A
167847	Chronic kidney disease, stage IIIA (moderate)	Diagnosis	N/A
167846	Human papillomavirus, mixed subtype	Organism	N/A
167846	HPV, mixed subtype	Organism	N/A
167845	HPV, subtype 18	Organism	N/A
167845	Human papillomavirus, subtype 18	Organism	N/A
167844	Human papillomavirus, subtype 16	Organism	N/A
167844	HPV, subtype 16	Organism	N/A
167843	Human papillomavirus subtype	Question	Coded
167843	Human papilloma virus subtype	Question	Coded
167843	HPV subtype	Question	Coded
167842	Replacement of left hip	Procedure	N/A
167842	Total arthroplasty of left hip	Procedure	N/A
167841	Total arthroplasty of right hip	Procedure	N/A
167841	Replacement of right hip	Procedure	N/A
167840	Being legally monitored	Question	Coded	Client is on probation, awaiting trial, or otherwise being legally monitored.
167839	Evidence for suicide risk	Question	Coded
167838	Procedure site	Question	Coded
167837	Alcohol Smoking and Substance Involvement Screening Test	Misc	N/A
167837	ASSIST	Misc	N/A
167836	Alcohol use disorders identification test	Misc	N/A
167836	AUDIT	Misc	N/A
167835	WHODAS 2.0	Misc	N/A
167835	World Health Organization Disability Assessment 2.0	Misc	N/A
167834	CAGE	Misc	N/A
167834	CAGE questionnaire	Misc	N/A
167833	GAF	Misc	N/A	The Global Assessment of Functioning (GAF) is a numeric scale used by mental health clinicians and physicians to rate subjectively the social, occupational, and psychological functioning of an individual, e.g., how well one is meeting various problems in living. Scores range from 100 (extremely high functioning) to 1 (severely impaired). The scale was included in DSM-IV, but replaced in DSM-5 with the WHODAS (WHO Disability Assessment Schedule), a survey or interview with detailed items. The WHODAS is supposed to be more detailed and objective than a single global impression. The main advantage of the GAF would be its brevity.[1] REF: Global Assessment of Functioning - Wikipedia
167833	Global assessment of functioning	Misc	N/A	The Global Assessment of Functioning (GAF) is a numeric scale used by mental health clinicians and physicians to rate subjectively the social, occupational, and psychological functioning of an individual, e.g., how well one is meeting various problems in living. Scores range from 100 (extremely high functioning) to 1 (severely impaired). The scale was included in DSM-IV, but replaced in DSM-5 with the WHODAS (WHO Disability Assessment Schedule), a survey or interview with detailed items. The WHODAS is supposed to be more detailed and objective than a single global impression. The main advantage of the GAF would be its brevity.[1] REF: Global Assessment of Functioning - Wikipedia
167832	GAD-7	Misc	N/A	The GAD-7 is useful in primary care and mental health settings as a screening tool and measure of symptom severity for the four most common anxiety disorders (generalized anxiety disorder, panic disorder, social phobia and post-traumatic stress disorder (PTSD).
167832	Generalized Anxiety Disorder 7 assessment tool	Misc	N/A	The GAD-7 is useful in primary care and mental health settings as a screening tool and measure of symptom severity for the four most common anxiety disorders (generalized anxiety disorder, panic disorder, social phobia and post-traumatic stress disorder (PTSD).
167831	PHQ-A	Misc	N/A
167831	Patient Health Questionnaire for adolescents	Misc	N/A
167830	Patient Health Questionnaire-9	Misc	N/A	An assessment tool
167830	PHQ-9	Misc	N/A	An assessment tool
167829	Number of hospitalizations since last visit	Question	Numeric
167829	Number of hospitalisations since last visit	Question	Numeric
167828	Local non-health-related authority	Misc	N/A	The organizations or individuals in charge of the public services for a community, such as police, national guard, etc.
167827	BF.7 variant	Misc	N/A	SARS-CoV-2 (COVID-19) virus variant
167826	XBB.1.5 variant	Misc	N/A	SARS-CoV-2 (COVID-19) virus variant

akanter · March 1, 2023, 3:03am

New version of CIEL dictionary has been added to dropbox AND updated on Open Concept Lab for February 27, 2023!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.11.4, 2.0.1, 2.1, 2.2, 2.3, 2.4 and 2.5. Note that I will no longer be releasing in versions prior to 1.11

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL.

https://app.openconceptlab.org/#/orgs/CIEL/

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release includes new concepts for PIH, the new Kenya HDD/KenyaEMR and improved concepts for drug treatment of mental health disorders, diabetes and other NCD usually part of quality reporting.

It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.

The drug table was not updated for this release. We are working on getting a new version of the drug table out, but if you are interested, reach out to me separately.

|concept_id|name|Class|Datatype|description|
|---|---|---|---|---|
|167968|Vasay|Drug|N/A||
|167968|Amlodipine / hydrochlorothiazide / nebivolol|Drug|N/A||
|167967|Etoricoxib|Drug|N/A||
|167966|Uloric|Drug|N/A||
|167966|Febuxostat|Drug|N/A||
|167965|Ezetimibe / rosuvastatin|Drug|N/A||
|167965|Roszet|Drug|N/A||
|167964|Zypitamag|Drug|N/A||
|167964|Pitavastatin|Drug|N/A||
|167964|Livalo|Drug|N/A||
|167963|Treatment not indicated|Finding|N/A||
|167962|Diabetic on insulin and oral therapy|Finding|N/A||
|167961|Diabetic on oral therapy only|Finding|N/A||
|167960|Diabetic on insulin therapy|Finding|N/A||
|167959|Diabetic on diet control only|Finding|N/A||
|167958|Diabetes treatment monitoring status|Question|Coded||
|167958|Diabetes treatment plan|Question|Coded||
|167957|Hypoglycaemia in past 30 days|Question|Coded||
|167957|Hypoglycemic episode in past month|Question|Coded||
|167956|Has glucose meter at home|Question|Coded||
|167956|Has glucometer at home|Question|Coded||
|167956|Possesses home glucometer|Question|Coded||
|167955|Objective narrative|Question|Text||
|167955|Objective note|Question|Text||
|167954|Subjective narrative|Question|Text||
|167954|Subjective note|Question|Text||
|167953|Iloperidone|Drug|N/A||
|167953|Fanapt|Drug|N/A||
|167952|Pimavanserin|Drug|N/A||
|167952|Nuplazid|Drug|N/A||
|167951|Vraylar|Drug|N/A||
|167951|Cariprazine|Drug|N/A||
|167950|Brexpiprazole|Drug|N/A||
|167950|Rexulti|Drug|N/A||
|167949|Invega|Drug|N/A||
|167949|Paliperidone|Drug|N/A||
|167948|Asenapine|Drug|N/A||
|167948|Saphris|Drug|N/A||
|167948|Secuado|Drug|N/A||
|167947|Latuda|Drug|N/A||
|167947|Lurasidone|Drug|N/A||
|167946|Lisdexamfetamine|Drug|N/A||
|167946|Vyvanse|Drug|N/A||
|167945|Azilsartan / chlorthalidone|Drug|N/A||
|167945|Edarbyclor|Drug|N/A||
|167944|Edarbi|Drug|N/A||
|167944|Azilsartan|Drug|N/A||
|167943|Sitagliptin|Drug|N/A||
|167943|Januvia|Drug|N/A||
|167942|Onglyza|Drug|N/A||
|167942|Saxagliptin|Drug|N/A||
|167941|Alogliptin|Drug|N/A||
|167941|Nesina|Drug|N/A||
|167940|Steglatro|Drug|N/A||
|167940|Ertugliflozin|Drug|N/A||
|167939|Jardiance|Drug|N/A||
|167939|Empagliflozin|Drug|N/A||
|167938|Dapagliflozin|Drug|N/A||
|167938|Farxiga|Drug|N/A||
|167937|Canagliflozin|Drug|N/A||
|167937|Invokana|Drug|N/A||
|167936|Wegovy|Drug|N/A||
|167936|Semaglutide|Drug|N/A||
|167936|Ozempic|Drug|N/A||
|167936|Rybelsus|Drug|N/A||
|167935|Adlyxin|Drug|N/A||
|167935|Lixisenatide|Drug|N/A||
|167934|Liraglutide|Drug|N/A||
|167934|Victoza|Drug|N/A||
|167934|Saxenda|Drug|N/A||
|167933|Dulaglutide|Drug|N/A||
|167933|Trulicity|Drug|N/A||
|167932|Tanzeum|Drug|N/A||
|167932|Albiglutide|Drug|N/A||
|167931|Alfrezza|Drug|N/A||
|167931|Insulin regular inhaled|Drug|N/A||
|167930|Insulin glargine / lixisenatide|Drug|N/A||
|167930|Soliqua|Drug|N/A||
|167929|Xultophy|Drug|N/A||
|167929|Insulin degludec / liraglutide|Drug|N/A||
|167928|Tresiba|Drug|N/A||
|167928|Insulin degludec|Drug|N/A||
|167927|Metformin / saxagliptin|Drug|N/A||
|167926|Prandimet|Drug|N/A||
|167926|Metformin / repaglinide|Drug|N/A||
|167925|Steglujan|Drug|N/A||
|167925|Ertugliflozin / sitagliptin|Drug|N/A||
|167924|Segluromet|Drug|N/A||
|167924|Ertugliflozin / metformin|Drug|N/A||
|167923|Empagliflozin / metformin|Drug|N/A||
|167923|Synjardy|Drug|N/A||
|167922|Empagliflozin / linagliptin / metformin|Drug|N/A||
|167922|Trijardy|Drug|N/A||
|167921|Glyxambi|Drug|N/A||
|167921|Empagliflozin / linagliptin|Drug|N/A||
|167920|Qtern|Drug|N/A||
|167920|Dapagliflozin / saxagliptin|Drug|N/A||
|167919|Ability to read and manage home glucometer|Question|Coded||
|167919|Has knowledge of how to operate home glucometer|Question|Coded||
|167918|Number of missed medication doses in past week|Question|Numeric||
|167918|Number of missed medication doses in past seven days|Question|Numeric||
|167917|Fundoscopy exam findings|Question|Coded||
|167917|Ophthalmoscopy exam findings|Question|Coded||
|167917|Fundoscopic exam findings|Question|Coded||
|167916|Fundoscopy exam performance status|Question|Coded||
|167916|Fundoscopic exam performance status|Question|Coded||
|167915|Oral hypoglycemic class|Pharmacologic Drug Class|N/A||
|167915|Oral blood glucose lowering medication class|Pharmacologic Drug Class|N/A||
|167915|Oral anti-diabetic medication class|Pharmacologic Drug Class|N/A||
|167914|Patient understands their treatment|Question|Coded||
|167913|Patient's condition/problem/disease controlled|Question|Coded||
|167912|Invokamet|Drug|N/A||
|167912|Canagliflozin / metformin|Drug|N/A||
|167911|Oseni|Drug|N/A||
|167911|Alogliptin / pioglitazone|Drug|N/A||
|167910|Kazano|Drug|N/A||
|167910|Alogliptin / metformin|Drug|N/A||
|167909|Namzaric|Drug|N/A||
|167909|Donepezil / memantine|Drug|N/A||
|167908|Left eye|Anatomy|N/A||
|167907|Right eye|Anatomy|N/A||
|167906|Passport number|Question|Text||
|167905|GMI|Test|Numeric||
|167905|Estimated hemoglobin A1c from continuous glucose monitoring|Test|Numeric||
|167905|Glucose management indicator|Test|Numeric||
|167904|Cerebral four vessel angiogram|Radiology/Imaging Procedure|N/A||
|167904|Cerebral four vessel arteriogram|Radiology/Imaging Procedure|N/A||
|167903|Galactogram|Radiology/Imaging Procedure|N/A||
|167903|Mammary ductogram|Radiology/Imaging Procedure|N/A||
|167902|X-ray of bilateral wrists|Radiology/Imaging Procedure|N/A||
|167902|Xray of both wrists|Radiology/Imaging Procedure|N/A||
|167901|Plain x-ray of right sacroiliac joint|Radiology/Imaging Procedure|N/A||
|167901|Plain xray of right sacroiliac joint|Radiology/Imaging Procedure|N/A||
|167900|Plain xray of left sacroiliac joint|Radiology/Imaging Procedure|N/A||
|167900|Plain x-ray of left sacroiliac joint|Radiology/Imaging Procedure|N/A||
|167900|X-ray of left sacroiliac joint|Radiology/Imaging Procedure|N/A||
|167900|Xray of left sacroiliac joint|Radiology/Imaging Procedure|N/A||
|167899|X-ray of right sternoclavicular joint|Radiology/Imaging Procedure|N/A||
|167899|Xray of right sternoclavicular joint|Radiology/Imaging Procedure|N/A||
|167898|X-ray of left sternoclavicular joint|Radiology/Imaging Procedure|N/A||
|167898|Xray of left sternoclavicular joint|Radiology/Imaging Procedure|N/A||
|167897|Ultrasound obstetric doppler|Radiology/Imaging Procedure|N/A||
|167896|Doppler ultrasound of renal artery|Radiology/Imaging Procedure|N/A||
|167895|X-ray of both sacroiliac joints|Radiology/Imaging Procedure|N/A||
|167895|Xray of bilateral sacroiliac joints|Radiology/Imaging Procedure|N/A||
|167894|Free PSA measurement|Test|Numeric||
|167894|Free prostate specific antigen (PSA) measurement (ng/mL)|Test|Numeric||
|167893|Endorectal US|Radiology/Imaging Procedure|N/A||
|167893|Endorectal ultrasound|Radiology/Imaging Procedure|N/A||
|167892|Ultrasound of prostate|Radiology/Imaging Procedure|N/A||
|167892|Prostate US|Radiology/Imaging Procedure|N/A||
|167891|Ultrasound of thyroid|Radiology/Imaging Procedure|N/A||
|167891|Thyroid US|Radiology/Imaging Procedure|N/A||
|167890|Carotid arteriography, bilateral|Radiology/Imaging Procedure|N/A||
|167890|Carotid angiography, bilateral|Radiology/Imaging Procedure|N/A||
|167889|Carotid angiography, unilateral|Radiology/Imaging Procedure|N/A||
|167889|Carotid arteriography, unilateral|Radiology/Imaging Procedure|N/A||
|167888|Administration of medication by nebulizer|Procedure|N/A||
|167887|Gastric lavage|Procedure|N/A||
|167887|Irrigation of stomach|Procedure|N/A||
|167886|Foley|Procedure|N/A||
|167886|Insertion of catheter into urinary bladder|Procedure|N/A||
|167886|Catheterization of urinary bladder|Procedure|N/A||
|167886|Catheterisation of urinary bladder|Procedure|N/A||
|167885|Removal of urinary bladder catheter|Procedure|N/A||
|167884|Perform triage|Procedure|N/A||
|167884|Triage|Procedure|N/A||
|167883|Taking patient vital signs|Procedure|N/A||
|167883|Evaluation of vital signs|Procedure|N/A||
|167882|First aid|Procedure|N/A||
|167882|Administer first aid|Procedure|N/A||
|167881|Preoperative care|Procedure|N/A||
|167881|Provide preoperative care|Procedure|N/A||
|167880|Postop care|Procedure|N/A||
|167880|Provide post-operative care|Procedure|N/A||
|167879|Computed tomography of heart|Radiology/Imaging Procedure|N/A||
|167879|Cardiac CT|Radiology/Imaging Procedure|N/A||
|167878|Maggi seasoning intake|Question|Coded|Intake of soy sauce or other salty seasoning|
|167878|Maggi sauce intake?|Question|Coded|Intake of soy sauce or other salty seasoning|
|167878|Soy sauce-like seasoning intake|Question|Coded|Intake of soy sauce or other salty seasoning|
|167877|Excessive table salt intake|Question|Coded||
|167877|Excess salt intake|Question|Coded||
|167876|Chemotherapy detail|ConvSet|N/A||
|167875|Total number of planned chemotherapy cycles|Question|Numeric||
|167874|Chemotherapy cycle number|Test|Numeric||
|167873|DBS|Misc|N/A||
|167873|Dried blood spot specimen|Misc|N/A||
|167873|Dried blood spot|Misc|N/A||
|167872|DPS|Misc|N/A||
|167872|Dried plasma spot specimen|Misc|N/A||
|167872|Dried plasma|Misc|N/A||
|167872|Dried plasma specimen|Misc|N/A||

akanter · April 5, 2023, 8:57pm

New version of CIEL dictionary has been added to dropbox AND will be soon available on Open Concept Lab for April 1, 2023! This is not a trick, or Fool’s Gold Lots of new content added!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.11.4, 2.0.1, 2.1, 2.2, 2.3, 2.4 and 2.5. Note that I will no longer be releasing in versions prior to 1.11

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL.

https://app.openconceptlab.org/#/orgs/CIEL/

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release includes a significant number of Spanish concept names where SAME-AS SNOMED content was previously available, new concepts for PIH, MSF, Cambodia and lots of new medication concepts for the new Kenya HDD/KenyaEMR among others.

The drug table was not updated for this release. We are working on getting a new version of the drug table out, but if you are interested, reach out to me separately.

The list of new concepts (English names):

concept_id	name	Class	Datatype	description
168058	Pabal	Drug	N/A
168058	Ecbosure	Drug	N/A
168058	Lonactene	Drug	N/A
168058	Riligol	Drug	N/A
168058	Carbetocin	Drug	N/A
168058	Caritec	Drug	N/A
168058	Cinomac	Drug	N/A
168058	Duratocin	Drug	N/A
168057	Diabetic foot ulcer risk level	Question	Coded
168056	Diabetic foot risk factor	Question	Coded
168055	History of foot amputation	Finding	N/A
168054	History of foot ulcer	Finding	N/A
168053	Foot pulse absent	Diagnosis	N/A
168052	Monofilament foot sensitivity test	Procedure	Coded
168051	Edurant	Drug	N/A
168051	Rilpivirine	Drug	N/A
168050	Vocabria	Drug	N/A
168050	Cabotegravir	Drug	N/A
168050	Apretude	Drug	N/A
168049	Dapivirine	Drug	N/A
168048	Vidala	Drug	N/A
168048	Vildader	Drug	N/A
168048	Vildalog	Drug	N/A
168048	Vinsorin	Drug	N/A
168048	Vilnip	Drug	N/A
168048	Vil-G	Drug	N/A
168048	Viglida	Drug	N/A
168048	Vildaphage	Drug	N/A
168048	Vildanat	Drug	N/A
168048	Vilshine	Drug	N/A
168048	Vildagliptin	Drug	N/A
168047	Agoviz	Drug	N/A
168047	Agotine	Drug	N/A
168047	Simelatin	Drug	N/A
168047	Noveltin	Drug	N/A
168047	Agodep	Drug	N/A
168047	Circaltin	Drug	N/A
168047	Agomelatine	Drug	N/A
168047	Agoprex	Drug	N/A
168047	Agopose	Drug	N/A
168047	Agosan	Drug	N/A
168047	Lupibliss	Drug	N/A
168046	Tuberculosis symptoms	Question	Coded
168045	OGTT, result	Question	Coded
168045	GTT, result	Question	Coded
168045	Oral glucose tolerance test, overall interpretation	Question	Coded
168044	Vortioxetine hydrobromide	Drug	N/A
168043	Vorsero	Drug	N/A
168043	Torvox	Drug	N/A
168043	Vortiray	Drug	N/A
168043	Vipca	Drug	N/A
168043	Trivoxetin	Drug	N/A
168043	Brintellix	Drug	N/A
168043	Vdep	Drug	N/A
168043	Vortica	Drug	N/A
168043	Vortioxetine	Drug	N/A
168043	Trintellix	Drug	N/A
168043	Voxitin	Drug	N/A
168043	Vortidif	Drug	N/A
168042	Gabapentin / mecobalamin	Drug	N/A
168042	Gabapentin / methylcobalamin	Drug	N/A
168041	Left ventricle depressed	Finding	N/A
168041	Depressed left ventricular ejection fraction	Finding	N/A
168040	Lulimac	Drug	N/A
168040	Emluz	Drug	N/A
168040	Lulizol	Drug	N/A
168040	L-Sys	Drug	N/A
168040	Lilituf	Drug	N/A
168040	Luliderm	Drug	N/A
168040	Lulibet	Drug	N/A
168040	Luzu	Drug	N/A
168040	Luly	Drug	N/A
168040	Luligee	Drug	N/A
168040	Lulifin	Drug	N/A
168040	Luliconazole	Drug	N/A
168039	Bimat-T	Drug	N/A
168039	Sightim	Drug	N/A
168039	Bimaton T	Drug	N/A
168039	Bimatoprost / timolol	Drug	N/A
168039	Intaprost T	Drug	N/A
168039	Careprost Plus	Drug	N/A
168039	Ganfort	Drug	N/A
168039	Xyprost TM	Drug	N/A
168039	Senzopt T	Drug	N/A
168039	Bimat LS TM	Drug	N/A
168039	Synoprost-T	Drug	N/A
168038	Fenceta Novo	Drug	N/A
168038	Aceclofenac / paracetamol	Drug	N/A
168038	Dolowin-Plus	Drug	N/A
168038	Anaflam XP	Drug	N/A
168038	Hifenac-P	Drug	N/A
168038	Aceclo Plus	Drug	N/A
168038	Parafast	Drug	N/A
168038	Jusgo	Drug	N/A
168038	Ark-AP	Drug	N/A
168038	Zerodol-P	Drug	N/A
168038	Acenac-P	Drug	N/A
168037	Completely dependent	Misc	N/A
168037	Unable to perform without assistance	Misc	N/A
168036	Independent with severe difficulties	Misc	N/A
168035	Independent with mild difficulties	Misc	N/A
168034	Independent	Misc	N/A
168034	Requires no assistance	Misc	N/A
168033	Aldigesic	Drug	N/A
168033	Aceclo-MR	Drug	N/A
168033	Dolofresh MR	Drug	N/A
168033	Acenext MR	Drug	N/A
168033	Acemiz-MR	Drug	N/A
168033	Dolokind-MR	Drug	N/A
168033	Hifenac-MR	Drug	N/A
168033	Movexx MR	Drug	N/A
168033	Dolowin-MR	Drug	N/A
168033	Acimol MR	Drug	N/A
168033	Facer-MR	Drug	N/A
168033	Aceclofenac / chlorzoxazone / paracetamol	Drug	N/A
168033	Aceclofenac / acetaminophen / chlorzoxazone	Drug	N/A
168032	Nadoxin	Drug	N/A
168032	Acuatim	Drug	N/A
168032	Nadifloxacin	Drug	N/A
168032	Nadiflox	Drug	N/A
168032	Nadixa	Drug	N/A
168032	Activon	Drug	N/A
168031	Follow-up evaluation	Procedure	N/A
168031	Re-evaluation procedure	Procedure	N/A
168030	SOAP note	Question	Text
168029	Hepatitis C genotype 6	Organism	N/A
168028	Hepatitis C genotype 5	Organism	N/A
168027	Hepatitis C genotype 4	Organism	N/A
168026	Hepatitis C genotype 3	Organism	N/A
168025	Hepatitis C genotype 2	Organism	N/A
168024	Hepatitis C genotype 1	Organism	N/A
168023	HCV genotype	Test	Coded	Blood test that analyzes the strain of the hepatitis C virus and classify in one of the 6 most common categories
168023	Hepatitis C virus genotype	Test	Coded	Blood test that analyzes the strain of the hepatitis C virus and classify in one of the 6 most common categories
168022	XBB.1.16 variant	Misc	N/A	SARS-CoV-2 (COVID-19) virus variant
168022	XBB.1.16	Misc	N/A	SARS-CoV-2 (COVID-19) virus variant
168021	XBB.1.9 variant	Misc	N/A	SARS-CoV-2 (COVID-19) virus variant
168020	Motivational interviewing	Procedure	N/A
168019	Schistosoma species identification in stool by concentration method	Test	Coded
168019	Schistosomiasis seen on light microscopy	Test	Coded
168019	S. mansoni identified in stool	Test	Coded
168018	Administration of Prevnar	Procedure	N/A
168018	Administration of 13-valent pneumococcal conjugate vaccine	Procedure	N/A
168017	HPV vaccination	Procedure	N/A
168017	Administration of human papilloma virus (HPV) vaccine	Procedure	N/A
168016	Shingrix	Drug	N/A
168016	Varicella zoster virus glycoprotein E vaccine, recombinant	Drug	N/A
168015	Varivax	Drug	N/A
168015	Zostavax	Drug	N/A
168015	Varicella virus vaccine, live	Drug	N/A
168014	Polio vaccine, bivalent, oral	Drug	N/A
168014	replace	Drug	N/A
168014	ipv	Drug	N/A
168013	Hemophilus influenza B immunization	Procedure	N/A
168013	Haemophilus influenzae B vaccination	Procedure	N/A
168013	Administration of conjugated Haemophilus influenzae type B vaccine	Procedure	N/A
168012	Polio vaccine, oral	Drug	N/A
168011	Administration of live, attenuated measles, mumps and rubella vaccine	Procedure	N/A
168011	MMR vaccination	Procedure	N/A
168010	Administration of influenza vaccine	Procedure	N/A
168010	Influenza vaccination	Procedure	N/A

akanter · April 5, 2023, 8:59pm

concept_id	name	Class	Datatype	description
168009	Aberin-M	Drug	N/A
168009	Gemer	Drug	N/A
168009	Azulix MF	Drug	N/A
168009	Glimisave M	Drug	N/A
168009	Glucoryl-M	Drug	N/A
168009	Geminor M	Drug	N/A
168009	Glycomet-GP	Drug	N/A
168009	Glimy M	Drug	N/A
168009	Glimestar-M	Drug	N/A
168009	Glimepiride / metformin	Drug	N/A
168009	Diapride M	Drug	N/A
168009	Gluconorm-G	Drug	N/A
168008	Bisolvon	Drug	N/A
168008	Pridin	Drug	N/A
168008	Duro-Tuss Chesty Cough Liquid Plus Nasal Decongestant	Drug	N/A
168008	Brex	Drug	N/A
168008	Brex S	Drug	N/A
168008	Solvin Expt	Drug	N/A
168008	Solkuf	Drug	N/A
168008	Bromhexine / pseudoephedrine	Drug	N/A
168008	Cofvyn	Drug	N/A
168007	Oricitral	Drug	N/A
168007	Alkel	Drug	N/A
168007	Disodium hydrogen citrate	Drug	N/A
168007	Alkasol	Drug	N/A
168007	Alkarate	Drug	N/A
168007	Adlizer	Drug	N/A
168007	Alkorina	Drug	N/A
168007	Cital	Drug	N/A
168007	Citralka	Drug	N/A
168007	Urosol	Drug	N/A
168007	Alkadip	Drug	N/A
168006	Ordent	Drug	N/A
168006	Orni-O	Drug	N/A
168006	Normet	Drug	N/A
168006	Oflomac OZ	Drug	N/A
168006	Zanocin OZ	Drug	N/A
168006	Zenflox-OZ	Drug	N/A
168006	O2H	Drug	N/A
168006	Onoff OZ	Drug	N/A
168006	O2 Tablet	Drug	N/A
168006	Saril	Drug	N/A
168006	Ornof	Drug	N/A
168006	Horn O	Drug	N/A
168006	Zorno	Drug	N/A
168006	Oflox OZ	Drug	N/A
168006	Oflokem OZ	Drug	N/A
168006	Ofloxacin / ornidazole	Drug	N/A
168006	Brakke	Drug	N/A
168006	Mahacef OZ	Drug	N/A
168006	Oflotas-OZ	Drug	N/A
168006	Nflox-TZ	Drug	N/A
168005	Amoxicillin / floxacillin	Drug	N/A
168005	Amoxicillin / flucloxacillin	Drug	N/A
168004	Rabifast-DSR	Drug	N/A
168004	Superia DSR	Drug	N/A
168004	Rekool D	Drug	N/A
168004	Rabicer DSR	Drug	N/A
168004	Cyra-D	Drug	N/A
168004	Mac-RD	Drug	N/A
168004	Veloz D	Drug	N/A
168004	Rabez D	Drug	N/A
168004	Bravia-DSR	Drug	N/A
168004	Rabalkem-DSR	Drug	N/A
168004	Rantac RD	Drug	N/A
168004	Rebozen-DSR	Drug	N/A
168004	Rablet D	Drug	N/A
168004	Rebez DSR	Drug	N/A
168004	Rabekind-DSR	Drug	N/A
168004	Peptard-D	Drug	N/A
168004	Rabicip D	Drug	N/A
168004	Pepcia-D	Drug	N/A
168004	Rabeloc RD	Drug	N/A
168004	Rzole DSR	Drug	N/A
168004	Rabezol DSR	Drug	N/A
168004	Acera-D	Drug	N/A
168004	Rapeed D	Drug	N/A
168004	Happi-D	Drug	N/A
168004	Rabium-DSR	Drug	N/A
168004	Rabesec-D	Drug	N/A
168004	Drego-D	Drug	N/A
168004	Rabonik DSR	Drug	N/A
168004	Razo-D	Drug	N/A
168004	Rabemac-DSR	Drug	N/A
168004	Domperidon / rabeprazole	Drug	N/A
168003	Methylcobalamin / pregabalin	Drug	N/A
168003	Mecobalamin / pregabalin	Drug	N/A
168002	Intacoxia P	Drug	N/A
168002	Etorvel-P	Drug	N/A
168002	Etowin P	Drug	N/A
168002	Etoford P	Drug	N/A
168002	Nucoxia P	Drug	N/A
168002	Etrik P	Drug	N/A
168002	Brutaflam-Plus	Drug	N/A
168002	Etoricoxib / paracetamol	Drug	N/A
168002	Etos P	Drug	N/A
168002	Acetaminophen / etoricoxib	Drug	N/A
168002	Etoril P	Drug	N/A
168002	Etoriday P	Drug	N/A
168001	Bladmir	Drug	N/A
168001	Lupin Mira	Drug	N/A
168001	Mirabig	Drug	N/A
168001	Mirasmart	Drug	N/A
168001	VesiBeta	Drug	N/A
168001	Mirbeg	Drug	N/A
168001	Miranix	Drug	N/A
168001	Myrbetriq	Drug	N/A
168001	Mirakem	Drug	N/A
168001	Mirabegron	Drug	N/A
168001	Mirago	Drug	N/A
168001	Miratas	Drug	N/A
168000	Angiotensin converting enzyme inhibitor indication present	Question	Coded
168000	Presence of indications for use of ACE inhibitor	Question	Coded
167999	Automated blood large platelet/platelet ratio	Test	Numeric
167999	Platelet-large cell ratio (P-LCR)	Test	Numeric
167998	On angiotensin-converting enzyme (ACE) inhibitors	Finding	Coded
167997	Adapalene / clindamycin	Drug	N/A
167997	Deriva-Cms	Drug	N/A
167997	Nilac A	Drug	N/A
167997	Femcinol-ADP	Drug	N/A
167997	Adaple-C	Drug	N/A
167997	Faceclin AT	Drug	N/A
167997	Acnesol A	Drug	N/A
167997	Adalene	Drug	N/A
167997	Acnovate	Drug	N/A
167997	Acnetor AD	Drug	N/A
167997	Nioclean AD	Drug	N/A
167997	167972	Drug	N/A
167996	Zesunate kit	Drug	N/A
167996	Arh plus kit	Drug	N/A
167996	Endomal SP	Drug	N/A
167996	Falciden kit	Drug	N/A
167996	Rtrit-SP combikit	Drug	N/A
167996	Artesunate + Pyrimethamine / sulfadoxine combination kit	Drug	N/A
167996	Falcynate kit	Drug	N/A
167996	Larinate kit	Drug	N/A
167996	Falciout kit	Drug	N/A
167996	Rtsunate SP	Drug	N/A
167996	Altinate kit	Drug	N/A
167995	Amoxicillin / clarithromycin / esomeprazole combination kit	Drug	N/A
167995	Sompraz HP combipack	Drug	N/A
167995	Pylokit-AC kit	Drug	N/A
167995	Esium-HP kit	Drug	N/A
167995	Nexpro HP combipack	Drug	N/A
167995	ESP-HP kit	Drug	N/A
167995	Esomac HP combo kit	Drug	N/A
167994	Clotrimazole / metronidazole	Drug	N/A
167994	Infa-V	Drug	N/A
167993	Fungin V	Drug	N/A
167993	Emplus-V	Drug	N/A
167993	Metronidazole / miconazole	Drug	N/A
167992	State (location)	Question	Text
167992	State	Question	Text
167991	Frequency of nursing observation required per hour	Question	Numeric
167990	Amlodipine / indapamide / perindopril	Drug	N/A
167990	Triplixam	Drug	N/A
167989	Hydrochlorothiazide / ramipril	Drug	N/A
167989	Ramihart-H	Drug	N/A
167989	Ramistar-H	Drug	N/A
167989	Ramcor-H	Drug	N/A
167989	Macpril H	Drug	N/A
167989	Cardace H	Drug	N/A
167989	Ramisave H	Drug	N/A
167989	Hopace-H	Drug	N/A
167988	Cerebroprotein Hydrolysate / piracetam	Drug	N/A
167988	Ceremax Plus	Drug	N/A
167988	Cerebrain Plus	Drug	N/A
167987	Cerebroprotein hydrolysate	Drug	N/A
167987	Stropin	Drug	N/A
167987	Cognifast	Drug	N/A
167987	Neurobrosin	Drug	N/A
167987	Cognistar	Drug	N/A
167987	Cerevate	Drug	N/A
167987	Zyneu	Drug	N/A
167987	Cerebrolysin	Drug	N/A
167987	Cerevion	Drug	N/A
167987	Cognitrac	Drug	N/A
167987	Cogniza	Drug	N/A
167986	Ostivestin	Drug	N/A
167986	Macvestin	Drug	N/A
167986	Rediflex	Drug	N/A
167986	Dolestin	Drug	N/A
167986	Corvestin	Drug	N/A
167986	Uniwin	Drug	N/A
167986	Univestin	Drug	N/A
167986	Lupivestin	Drug	N/A
167986	Flavestin	Drug	N/A
167986	Uniortho	Drug	N/A
167986	Visentin	Drug	N/A
167985	Cyonase-TH	Drug	N/A
167985	Loxifast	Drug	N/A
167985	Flexispaz	Drug	N/A
167985	Lorqrs T	Drug	N/A
167985	Lornoxicam / thiocolchicoside	Drug	N/A
167985	Lortag MR	Drug	N/A
167985	Relor-T	Drug	N/A
167985	Zenlong T	Drug	N/A
167985	Noxica-TH	Drug	N/A
167985	Ostiflex MR	Drug	N/A
167984	Betamethasone / chlorpheniramine	Drug	N/A
167984	Betomin	Drug	N/A
167984	Saccortin	Drug	N/A
167984	Celestamine	Drug	N/A
167984	Emperacin	Drug	N/A
167984	Celestana	Drug	N/A
167984	Histablock	Drug	N/A
167984	Puradesmin	Drug	N/A
167984	Almetamine	Drug	N/A
167984	Bedaramine	Drug	N/A
167984	Betaselemin	Drug	N/A
167983	Vaginobact	Drug	N/A
167983	Azithromycin / fluconazole / ornidazole	Drug	N/A
167982	Refozi MV	Drug	N/A
167982	Remo-Zen MV	Drug	N/A
167982	Remo MV	Drug	N/A
167982	Metformin / remogliflozin etabonate / vildagliptin	Drug	N/A
167981	Vildamac M	Drug	N/A
167981	Torglip M	Drug	N/A
167981	Vildapride M	Drug	N/A
167981	Abvida-M	Drug	N/A
167981	Gliptagreat M	Drug	N/A
167981	Metformin / vildagliptin	Drug	N/A
167981	Vylda-M	Drug	N/A
167981	Galvus Met	Drug	N/A
167981	Zavamet	Drug	N/A
167981	Jalra-M	Drug	N/A
167981	Encelin M	Drug	N/A
167981	Verifica-M	Drug	N/A
167980	Alduet	Drug	N/A
167980	Cetirizine / montelukast	Drug	N/A
167980	Aleut	Drug	N/A
167979	Synriam	Drug	N/A
167979	Synriam DT	Drug	N/A
167979	Arterolane / Piperaquine	Drug	N/A
167978	Esium-HP kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167978	Espentral-HP kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167978	Clariday-kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167978	Sign kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167978	Nexiken kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167978	Nulogut HP kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167978	Nexpro HP	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167978	Esogrot-HP kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167978	Sompraz HP	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167978	Esmostrum HP kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167978	Clarithromycin / Esomeprazole / Levofloxacin combination kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167978	Pylokit-AC	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167977	Laekit h-pylori kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167977	Esose HP Kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167977	Amoxicillin / Esomeprazole / Levofloxacin combination kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167976	Exospas Plus	Drug	N/A
167976	Buscodac P	Drug	N/A
167976	Belic	Drug	N/A
167976	Buscopan Plus	Drug	N/A
167976	Hyoscine butylbromide / Paracetamol	Drug	N/A
167976	Buscomide	Drug	N/A
167976	Gastreco P	Drug	N/A
167976	Hyocimax Plus	Drug	N/A
167976	Dolokind Spas	Drug	N/A
167976	Acetaminophen / hyoscine butylbromide	Drug	N/A
167976	Dolokind Spas RF	Drug	N/A
167975	Natrilam	Drug	N/A
167975	Amlodipine / indapamide	Drug	N/A
167975	Amlodac-D	Drug	N/A
167974	Nebifid AM	Drug	N/A
167974	Nebifast A	Drug	N/A
167974	Nebycare AM	Drug	N/A
167974	Nebivol SA	Drug	N/A
167974	Amlodipine / nebivolol	Drug	N/A
167974	Nebipil SA	Drug	N/A
167974	Nebilong-AM	Drug	N/A
167974	Nebula AM	Drug	N/A
167974	Nodon AM	Drug	N/A
167974	Nevy A	Drug	N/A
167974	Nebi-AM	Drug	N/A
167973	Late	Misc	N/A	General qualifier for something that occurred after the middle or expected time.
167972	On time	Misc	N/A
167972	Punctual	Misc	N/A
167971	Early	Misc	N/A	General qualifier that something occurred before the middle or expected time.
167970	Patient arrival timing	Question	Coded
167970	Patient arrival timing	Question	Coded
167970	Visit punctuality	Question	Coded
167969	Insurance number	Question	Text

akanter · April 6, 2023, 5:39pm

The new version is now on OCL as well!

akanter · July 14, 2023, 1:21pm

New version of CIEL dictionary has been added to dropbox and on Open Concept Lab for July 12, 2023!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.11.6, 2.0.1, 2.1, 2.2, 2.3, 2.5 and 2.5. Note that I will no longer be releasing in versions prior to 1.11

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT THE DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL.

https://app.openconceptlab.org/#/orgs/CIEL/

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release includes new concepts for COVID variants, PIH, Oncology outcomes, Cambodia and lots of new medication concepts for the new Kenya HDD/KenyaEMR among others.

The drug table was not updated for this release. We are working on getting a new version of the drug table out, but if you are interested, reach out to me separately.

The list of new concepts (English names):

concept_id	name	Class	Datatype	description
168164	Cilogard	Drug	N/A
168164	Atelec	Drug	N/A
168164	Cilnidipine	Drug	N/A
168164	Cilacar	Drug	N/A
168164	Nulong	Drug	N/A
168164	Rancil	Drug	N/A
168164	Torcilin	Drug	N/A
168164	Cilaheart	Drug	N/A
168164	Twincal	Drug	N/A
168164	Dilnip	Drug	N/A
168164	Ciladuo	Drug	N/A
168164	Cilnikem	Drug	N/A
168164	Nexovas	Drug	N/A
168163	Overall RECIST	Question	Coded
168163	Solid tumour overall response to therapy	Question	Coded
168163	Solid tumor overall response to treatment	Question	Coded
168162	Not all lesions evaluated	Finding	N/A
168161	RECIST tumor response set	ConvSet	N/A
168161	RECIST	ConvSet	N/A
168161	Response Evaluation Criteria in Solid Tumours response set	ConvSet	N/A
168161	Response Evaluation Criteria in Solid Tumors response set	ConvSet	N/A
168160	non-CR/non-PD	Finding	N/A
168160	Non-complete response / non-progressive disease	Finding	N/A
168160	No complete response / no progressive disease	Finding	N/A
168159	Not evaluatable	Finding	N/A
168159	Inevaluable	Finding	N/A
168159	Not evaluable (NE)	Finding	N/A
168158	Disease progressing on treatment	Finding	N/A
168158	Progressive disease on therapy (PD)	Finding	N/A
168157	Disease condition stable	Finding	N/A
168157	Disease stable (DS)	Finding	N/A
168157	Disease stable	Finding	N/A
168156	Partial response to therapy (PR)	Finding	N/A
168156	Partial therapeutic response	Finding	N/A
168155	Complete therapeutic response	Finding	N/A
168155	Complete response to therapy (CR)	Finding	N/A
168154	Placental growth factor, serum (pg/mL)	Test	Numeric
168154	PIGF	Test	Numeric
168153	sFlt-1	Test	Numeric
168153	Soluble fms-like tyrosine kinase-1, serum (pg/mL)	Test	Numeric
168152	sFlt-1/PIGF panel	LabSet	N/A	Soluble fms-like tyrosine kinase-1 and placental growth factor panel used for predicting pre-eclampsia.
168152	Soluble fms-like tyrosine kinase-1 and placental growth factor panel	LabSet	N/A	Soluble fms-like tyrosine kinase-1 and placental growth factor panel used for predicting pre-eclampsia.
168151	Soluble fms-like tyrosine kinase-1/placental growth factor, serum	Test	Numeric
168151	pre-eclampsia test	Test	Numeric
168151	sFlt-1/PIGF ratio	Test	Numeric
168150	Discharge treatment plan	Question	Coded
168149	Patient able to self-titrate diuretics	Question	Coded
168148	Referred for surgical evaluation	Question	Coded
168148	Referred to surgical service	Question	Coded
168147	Vulnerable women and/or girls (VWG)	Misc	N/A
168146	Type of service provided	Question	Coded
168145	Quarterly	Frequency	N/A
168145	Trimonthly	Frequency	N/A
168144	Docker/freight handler	Misc	N/A
168143	Blood smear morphology panel	Test	Coded
168142	Biochemical nutritional assessment	Procedure	N/A
168141	Anthropometric nutritional assessment	Procedure	N/A
168141	Anthropometrics	Procedure	N/A
168140	Hormone therapy	Procedure	N/A
168140	Endocrine therapy	Procedure	N/A
168139	Chemoradiation therapy	Procedure	N/A
168139	Combined chemotherapy and radiation therapy	Procedure	N/A
168139	Concurrent chemotherapy	Procedure	N/A
168138	Magnetic resonance imaging (MRI) modality	Radiology/Imaging Procedure	N/A
168137	Diagnosis requiring palliative treatment	Question	Coded
168136	C-peptide in serum/plasma (ng/mL)	Test	Numeric
168135	Refractory heart failure	Diagnosis	N/A
168134	Long-acting morphine	Pharmacologic Drug Class	N/A	Subclass of morphine drug class
168133	Short acting morphine	Misc	N/A	Subclass of products containing morphine
168133	Short-acting morphine	Misc	N/A	Subclass of products containing morphine
168132	Nephrotic syndrome with membranous glomerulonephritis	Diagnosis	N/A
168131	Improvement seen on echocardiogram	Question	Coded
168130	Personal email address	Question	Text
168130	Individual e-mail address	Question	Text
168129	Country of citizenship	Question	Coded
168129	Nationality	Question	Coded
168128	Chemotherapy-induced cardiomyopathy	Diagnosis	N/A
168128	Cardiomyopathy due to chemotherapy	Diagnosis	N/A
168127	Pericarditis due to human immunodeficiency virus	Diagnosis	N/A
168127	HIV pericarditis	Diagnosis	N/A
168126	Patient adjusted insulin based on glucometer results	Question	Coded
168126	Patient adjusted insulin dose based on personal glucometer result	Question	Coded
168125	Number of episodes of hypoglycaemia in past 30 days	Question	Numeric
168125	Number of hypoglycemic episode(s) in past month	Question	Numeric
168124	Hematoma at injection site	Diagnosis	N/A
168123	Complications at injection site	Question	Coded
168122	Lipohypertrophy	Diagnosis	N/A
168121	Skin tenting	Finding	N/A
168121	Loss of skin turgor	Finding	N/A
168121	Slow skin pinch	Finding	N/A
168121	Decreased skin turgor	Finding	N/A
168120	Never been homeless	Finding	N/A
168119	History of homelessness	Finding	N/A
168118	Homelessness status	Question	Coded
168117	Immunohistochemistry test needed	Question	Coded
168116	Cardiomyopathy due to hypertension	Diagnosis	N/A
168116	Hypertensive cardiomyopathy	Diagnosis	N/A
168115	Adherence to low salt diet	Question	Coded
168114	Rotavirus antigen presence in stool	Test	Coded
168113	Tecovirimat	Drug	N/A
168113	Tpoxx	Drug	N/A
168112	Amtas Prp	Drug	N/A
168112	Rindopril AM	Drug	N/A
168112	Prestalia	Drug	N/A
168112	Coveril-AM	Drug	N/A
168112	Cardiomart AP	Drug	N/A
168112	Coversyl-AM	Drug	N/A
168112	Perindosyl AM	Drug	N/A
168112	Amlodipine / perindopril	Drug	N/A
168111	Vincent’s gingivitis	Diagnosis	N/A
168111	Vincent's gingivitis	Diagnosis	N/A
168111	ANUG (acute necrotizing ulcerative gingivitis)	Diagnosis	N/A
168111	Vincent disease	Diagnosis	N/A
168111	Acute necrotizing ulcerative gingivitis	Diagnosis	N/A
168111	Vincent’s gingivitis	Diagnosis	N/A
168111	Trench mouth	Diagnosis	N/A
168110	ANUS (acute necrotizing ulcerative stomatitis)	Diagnosis	Text
168110	ANUG (acute necrotizing ulcerative stomatitis)	Diagnosis	Text
168110	Acute necrotizing ulcerative stomatitis	Diagnosis	Text
168109	TSQ (Trauma Screening Questionnaire) score	Question	Numeric
168109	TSQ score	Question	Numeric
168109	Trauma Screening Questionnaire score	Question	Numeric
168108	HIV viral load detail	ConvSet	N/A
168107	Hemoglobin SC genotype	Finding	N/A
168107	HbSC	Finding	N/A
168107	Sickle cell-hemoglobin C disease	Finding	N/A
168107	Haemoglobin SC genotype	Finding	N/A
168107	Sickle cell-haemoglobin C disease	Finding	N/A
168106	HbAA (normal)	Finding	N/A
168106	HbAA	Finding	N/A
168106	Hemoglobin AA genotype	Finding	N/A
168106	Haemoglobin AA genotype	Finding	N/A
168105	Sickle cell rapid screening test	Test	Coded
168105	Sickle SCAN	Test	Coded
168104	Total current lifetime dose of drug received detail	ConvSet	N/A
168103	Total current lifetime dose of drug received	Question	Numeric
168102	Momisoft-F	Drug	N/A
168102	Mfsudif	Drug	N/A
168102	Hhfudic	Drug	N/A
168102	Fuzi M	Drug	N/A
168102	Momoz F	Drug	N/A
168102	Mometasone / fusidic acid	Drug	N/A
168102	Momalin	Drug	N/A
168102	Metasone F	Drug	N/A
168102	Etaze-ID	Drug	N/A
168102	Fusiwal M	Drug	N/A
168102	Motimesh SF	Drug	N/A
168101	Levocet M	Drug	N/A
168101	Laveta M	Drug	N/A
168101	Odimont-LC	Drug	N/A
168101	Lecope-M	Drug	N/A
168101	Montek LC	Drug	N/A
168101	Montemac-L	Drug	N/A
168101	Montina-L	Drug	N/A
168101	Levocetirizine / montelukast	Drug	N/A
168101	Monticope	Drug	N/A
168101	Montair LC	Drug	N/A
168101	L Montus	Drug	N/A
168100	Lower limit of detection	Question	Numeric	A generic concept for a limit. One example of use, an instrument reports Viral load is less than a value (ie. > 500).
168099	Medication dispense status reason	ConvSet	N/A
168098	Washout period	Misc	N/A	The period of time when a drug or medication is still present in the system after it has been stopped.
168097	Surgical procedure scheduled	Misc	N/A
168097	Surgery upcoming	Misc	N/A
168097	Surgery planned	Misc	N/A
168096	Suspected intolerance to drug	Finding	N/A	The patient is believed to have an intolerance to a substance that is part of the therapy and the therapy is being temporarily withdrawn to confirm.
168095	Duplicate therapy	Misc	N/A
168094	Mother pregnant or currently breastfeeding	Finding	N/A
168093	Drug would interfere with upcoming laboratory testing	Misc	N/A	The therapy would interfere with a planned lab test and the therapy is being withdrawn until the test is completed.
168093	Lab interference	Misc	N/A	The therapy would interfere with a planned lab test and the therapy is being withdrawn until the test is completed.
168092	Drug level too high to continue treatment	Finding	N/A
168091	Prescription/request requires clarification	Misc	N/A
168090	Try another treatment first	Misc	N/A	This therapy has been ordered as a backup to a preferred therapy. This order will be released when and if the preferred therapy is unsuccessful.
168089	Unable to provide necessary care	Misc	N/A	Fulfiller not able to provide appropriate care associated with fulfilling the order. Example: Therapy requires ongoing monitoring by fulfiller and fulfiller will be ending practice, leaving town, unable to schedule necessary time, etc.
168088	Religious/ethical objection	Misc	N/A	The provider has ethical, religious or moral objections to fulfilling a task such as dispensing a medication.
168087	Insufficient information	Misc	N/A
168087	Incomplete data	Misc	N/A
168086	Order too old to accept	Misc	N/A	Order has not been fulfilled within a reasonable amount of time, and might not be current.
168086	Stale-dated order	Misc	N/A	Order has not been fulfilled within a reasonable amount of time, and might not be current.
168085	Ordered stopped	Misc	N/A	The order has been stopped by the prescriber but this fact has not necessarily captured electronically. Example: A verbal stop, a fax, etc.
168085	Order discontinued	Misc	N/A	The order has been stopped by the prescriber but this fact has not necessarily captured electronically. Example: A verbal stop, a fax, etc.
168084	MedicationDispense Status Reason	ConvSet	N/A	http://terminology.hl7.org/fhir/CodeSystem/medicationdispense-status-reason
168083	XBC.1.6 variant	Misc	N/A	SARS-CoV-2 (COVID-19) virus variant
168082	Ability to apply perfume	Question	Coded
168081	Ability to brush teeth	Question	Coded
168080	Ability to use nail clippers	Question	Coded
168079	Ability to brush/comb/braid hair	Question	Coded
168079	Ability to manage hair	Question	Coded
168079	Ability to take care of hair	Question	Coded
168078	Ability to turn operate faucets	Question	Coded
168078	Ability to turn on/off faucets	Question	Coded
168078	Ability to turn on/off taps	Question	Coded
168077	Ability to dry oneself after washing/bathing	Question	Coded
168076	Ability to manage clothing before and after toileting	Question	Coded
168075	Ability to obtain and use toileting supplies	Question	Coded
168074	History of therapy with nephrotoxic drug	Finding	N/A
168074	History of therapy with nephrotoxic medication	Finding	N/A
168073	Spirometry results set	ConvSet	N/A
168072	Response to bronchodilator	Question	Coded
168071	FEV1/FVC	Test	Numeric
168071	Forced expiratory volume in one second / forced vital capacity ratio	Test	Numeric
168070	Forced vital capacity (FVC) (liters)	Test	Numeric
168070	FVC	Test	Numeric
168069	Forced expiratory volume in one second (FEV1) (liters)	Test	Numeric
168069	FEV1	Test	Numeric
168068	Amino acids, electrolytes, dextrose and lipid injectable emulsion	Drug	N/A
168068	Kabiven Total Parenteral Nutrition (TPN)	Drug	N/A
168067	History of long-term use of non-steroidal anti-inflammatory drugs (NSAIDs)	Finding	N/A
168066	Minimal change glomerulopathy	Diagnosis	N/A
168065	Treatment for chronic lung disease	Question	Coded
168064	LAMA	Pharmacologic Drug Class	N/A
168064	Long-acting muscarinic antagonists (LAMAs)	Pharmacologic Drug Class	N/A
168064	Long-acting muscarinic antagonists	Pharmacologic Drug Class	N/A
168063	LABA	Pharmacologic Drug Class	N/A
168063	Long-acting beta agonists (LABAs)	Pharmacologic Drug Class	N/A
168063	Long-acting beta agonists	Pharmacologic Drug Class	N/A
168062	SAMA	Pharmacologic Drug Class	N/A
168062	Short-acting muscarinic antagonists (SAMAs)	Pharmacologic Drug Class	N/A
168062	Short-acting muscarinic antagonists	Pharmacologic Drug Class	N/A
168061	Short-acting beta agonists (SABAs)	Pharmacologic Drug Class	N/A
168061	SABA	Pharmacologic Drug Class	N/A
168061	Short-acting beta agonists	Pharmacologic Drug Class	N/A
168060	Oral glucocorticoids	Pharmacologic Drug Class	N/A
168060	Oral steroids	Pharmacologic Drug Class	N/A
168059	Inhaled glucocorticoids	Pharmacologic Drug Class	N/A
168059	Inhaled steroids	Pharmacologic Drug Class	N/A
168058	Pabal	Drug	N/A
168058	Ecbosure	Drug	N/A
168058	Lonactene	Drug	N/A
168058	Riligol	Drug	N/A
168058	Carbetocin	Drug	N/A
168058	Caritec	Drug	N/A
168058	Cinomac	Drug	N/A
168058	Duratocin	Drug	N/A
168057	Diabetic foot ulcer risk level	Question	Coded
168056	Diabetic foot risk factor	Question	Coded
168055	History of foot amputation	Finding	N/A
168054	History of foot ulcer	Finding	N/A
168053	Foot pulse absent	Diagnosis	N/A
168052	Monofilament foot sensitivity test	Procedure	Coded
168051	Edurant	Drug	N/A
168051	Rilpivirine	Drug	N/A
168050	Vocabria	Drug	N/A
168050	Cabotegravir	Drug	N/A
168050	Apretude	Drug	N/A
168049	Dapivirine	Drug	N/A
168048	Vidala	Drug	N/A
168048	Vildader	Drug	N/A
168048	Vildalog	Drug	N/A
168048	Vinsorin	Drug	N/A
168048	Vilnip	Drug	N/A
168048	Vil-G	Drug	N/A
168048	Viglida	Drug	N/A
168048	Vildaphage	Drug	N/A
168048	Vildanat	Drug	N/A
168048	Vilshine	Drug	N/A
168048	Vildagliptin	Drug	N/A
168047	Agoviz	Drug	N/A
168047	Agotine	Drug	N/A
168047	Simelatin	Drug	N/A
168047	Noveltin	Drug	N/A
168047	Agodep	Drug	N/A
168047	Circaltin	Drug	N/A
168047	Agomelatine	Drug	N/A
168047	Agoprex	Drug	N/A
168047	Agopose	Drug	N/A
168047	Agosan	Drug	N/A
168047	Lupibliss	Drug	N/A
168046	Tuberculosis symptoms	Question	Coded
168045	OGTT, result	Question	Coded
168045	GTT, result	Question	Coded
168045	Oral glucose tolerance test, overall interpretation	Question	Coded
168044	Vortioxetine hydrobromide	Drug	N/A
168043	Vorsero	Drug	N/A
168043	Torvox	Drug	N/A
168043	Vortiray	Drug	N/A
168043	Vipca	Drug	N/A
168043	Trivoxetin	Drug	N/A
168043	Brintellix	Drug	N/A
168043	Vdep	Drug	N/A
168043	Vortica	Drug	N/A
168043	Vortioxetine	Drug	N/A
168043	Trintellix	Drug	N/A
168043	Voxitin	Drug	N/A
168043	Vortidif	Drug	N/A
168042	Gabapentin / mecobalamin	Drug	N/A
168042	Gabapentin / methylcobalamin	Drug	N/A
168041	Left ventricle depressed	Finding	N/A
168041	Depressed left ventricular ejection fraction	Finding	N/A
168040	Lulimac	Drug	N/A
168040	Emluz	Drug	N/A
168040	Lulizol	Drug	N/A
168040	L-Sys	Drug	N/A
168040	Lilituf	Drug	N/A
168040	Luliderm	Drug	N/A
168040	Lulibet	Drug	N/A
168040	Luzu	Drug	N/A
168040	Luly	Drug	N/A
168040	Luligee	Drug	N/A
168040	Lulifin	Drug	N/A
168040	Luliconazole	Drug	N/A
168039	Bimat-T	Drug	N/A
168039	Sightim	Drug	N/A
168039	Bimaton T	Drug	N/A
168039	Bimatoprost / timolol	Drug	N/A
168039	Intaprost T	Drug	N/A
168039	Careprost Plus	Drug	N/A
168039	Ganfort	Drug	N/A
168039	Xyprost TM	Drug	N/A
168039	Senzopt T	Drug	N/A
168039	Bimat LS TM	Drug	N/A
168039	Synoprost-T	Drug	N/A
168038	Fenceta Novo	Drug	N/A
168038	Aceclofenac / paracetamol	Drug	N/A
168038	Dolowin-Plus	Drug	N/A
168038	Anaflam XP	Drug	N/A
168038	Hifenac-P	Drug	N/A
168038	Aceclo Plus	Drug	N/A
168038	Parafast	Drug	N/A
168038	Jusgo	Drug	N/A
168038	Ark-AP	Drug	N/A
168038	Zerodol-P	Drug	N/A
168038	Acenac-P	Drug	N/A
168037	Completely dependent	Misc	N/A
168037	Unable to perform without assistance	Misc	N/A
168036	Independent with severe difficulties	Misc	N/A
168035	Independent with mild difficulties	Misc	N/A
168034	Independent	Misc	N/A
168034	Requires no assistance	Misc	N/A
168033	Aldigesic	Drug	N/A
168033	Aceclo-MR	Drug	N/A
168033	Dolofresh MR	Drug	N/A
168033	Acenext MR	Drug	N/A
168033	Acemiz-MR	Drug	N/A
168033	Dolokind-MR	Drug	N/A
168033	Hifenac-MR	Drug	N/A
168033	Movexx MR	Drug	N/A
168033	Dolowin-MR	Drug	N/A
168033	Acimol MR	Drug	N/A
168033	Facer-MR	Drug	N/A
168033	Aceclofenac / chlorzoxazone / paracetamol	Drug	N/A
168033	Aceclofenac / acetaminophen / chlorzoxazone	Drug	N/A
168032	Nadoxin	Drug	N/A
168032	Acuatim	Drug	N/A
168032	Nadifloxacin	Drug	N/A
168032	Nadiflox	Drug	N/A
168032	Nadixa	Drug	N/A
168032	Activon	Drug	N/A
168031	Follow-up evaluation	Procedure	N/A
168031	Re-evaluation procedure	Procedure	N/A
168030	SOAP note	Question	Text
168029	Hepatitis C genotype 6	Organism	N/A
168028	Hepatitis C genotype 5	Organism	N/A
168027	Hepatitis C genotype 4	Organism	N/A
168026	Hepatitis C genotype 3	Organism	N/A
168025	Hepatitis C genotype 2	Organism	N/A
168024	Hepatitis C genotype 1	Organism	N/A
168023	HCV genotype	Test	Coded	Blood test that analyzes the strain of the hepatitis C virus and classify in one of the 6 most common categories
168023	Hepatitis C virus genotype	Test	Coded	Blood test that analyzes the strain of the hepatitis C virus and classify in one of the 6 most common categories
168022	Arcturus variant	Misc	N/A	SARS-CoV-2 (COVID-19) virus variant
168022	XBB.1.16 variant	Misc	N/A	SARS-CoV-2 (COVID-19) virus variant
168022	XBB.1.16	Misc	N/A	SARS-CoV-2 (COVID-19) virus variant
168021	XBB.1.9 variant	Misc	N/A	SARS-CoV-2 (COVID-19) virus variant
168020	Motivational interviewing	Procedure	N/A
168019	Schistosoma species identification in stool by concentration method	Test	Coded
168019	Schistosomiasis seen on light microscopy	Test	Coded
168019	S. mansoni identified in stool	Test	Coded
168018	Administration of Prevnar	Procedure	N/A
168018	Administration of 13-valent pneumococcal conjugate vaccine	Procedure	N/A
168017	HPV vaccination	Procedure	N/A
168017	Administration of human papilloma virus (HPV) vaccine	Procedure	N/A
168016	Shingrix	Drug	N/A
168016	Varicella zoster virus glycoprotein E vaccine, recombinant	Drug	N/A
168015	Varivax	Drug	N/A
168015	Zostavax	Drug	N/A
168015	Varicella virus vaccine, live	Drug	N/A
168014	Polio vaccine, bivalent, oral	Drug	N/A
168014	replace	Drug	N/A
168014	ipv	Drug	N/A
168013	Hemophilus influenza B immunization	Procedure	N/A
168013	Haemophilus influenzae B vaccination	Procedure	N/A
168013	Administration of conjugated Haemophilus influenzae type B vaccine	Procedure	N/A
168012	Polio vaccine, oral	Drug	N/A
168011	Administration of live, attenuated measles, mumps and rubella vaccine	Procedure	N/A
168011	MMR vaccination	Procedure	N/A
168010	Administration of influenza vaccine	Procedure	N/A
168010	Influenza vaccination	Procedure	N/A
168009	Aberin-M	Drug	N/A
168009	Gemer	Drug	N/A
168009	Azulix MF	Drug	N/A
168009	Glimisave M	Drug	N/A
168009	Glucoryl-M	Drug	N/A
168009	Geminor M	Drug	N/A
168009	Glycomet-GP	Drug	N/A
168009	Glimy M	Drug	N/A
168009	Glimestar-M	Drug	N/A
168009	Glimepiride / metformin	Drug	N/A
168009	Diapride M	Drug	N/A
168009	Gluconorm-G	Drug	N/A
168008	Bisolvon	Drug	N/A
168008	Pridin	Drug	N/A
168008	Duro-Tuss Chesty Cough Liquid Plus Nasal Decongestant	Drug	N/A
168008	Brex	Drug	N/A
168008	Brex S	Drug	N/A
168008	Solvin Expt	Drug	N/A
168008	Solkuf	Drug	N/A
168008	Bromhexine / pseudoephedrine	Drug	N/A
168008	Cofvyn	Drug	N/A
168007	Oricitral	Drug	N/A
168007	Alkel	Drug	N/A
168007	Disodium hydrogen citrate	Drug	N/A
168007	Alkasol	Drug	N/A
168007	Alkarate	Drug	N/A
168007	Adlizer	Drug	N/A
168007	Alkorina	Drug	N/A
168007	Cital	Drug	N/A
168007	Citralka	Drug	N/A
168007	Urosol	Drug	N/A
168007	Alkadip	Drug	N/A
168006	Ordent	Drug	N/A
168006	Orni-O	Drug	N/A
168006	Normet	Drug	N/A
168006	Oflomac OZ	Drug	N/A
168006	Zanocin OZ	Drug	N/A
168006	Zenflox-OZ	Drug	N/A
168006	O2H	Drug	N/A
168006	Onoff OZ	Drug	N/A
168006	O2 Tablet	Drug	N/A
168006	Saril	Drug	N/A
168006	Ornof	Drug	N/A
168006	Horn O	Drug	N/A
168006	Zorno	Drug	N/A
168006	Oflox OZ	Drug	N/A
168006	Oflokem OZ	Drug	N/A
168006	Ofloxacin / ornidazole	Drug	N/A
168006	Brakke	Drug	N/A
168006	Mahacef OZ	Drug	N/A
168006	Oflotas-OZ	Drug	N/A
168006	Nflox-TZ	Drug	N/A
168005	Amoxicillin / floxacillin	Drug	N/A
168005	Amoxicillin / flucloxacillin	Drug	N/A
168004	Rabifast-DSR	Drug	N/A
168004	Superia DSR	Drug	N/A
168004	Rekool D	Drug	N/A
168004	Rabicer DSR	Drug	N/A
168004	Cyra-D	Drug	N/A
168004	Mac-RD	Drug	N/A
168004	Veloz D	Drug	N/A
168004	Rabez D	Drug	N/A
168004	Bravia-DSR	Drug	N/A
168004	Rabalkem-DSR	Drug	N/A
168004	Rantac RD	Drug	N/A
168004	Rebozen-DSR	Drug	N/A
168004	Rablet D	Drug	N/A
168004	Rebez DSR	Drug	N/A
168004	Rabekind-DSR	Drug	N/A
168004	Peptard-D	Drug	N/A
168004	Rabicip D	Drug	N/A
168004	Pepcia-D	Drug	N/A
168004	Rabeloc RD	Drug	N/A
168004	Rzole DSR	Drug	N/A
168004	Rabezol DSR	Drug	N/A
168004	Acera-D	Drug	N/A
168004	Rapeed D	Drug	N/A
168004	Happi-D	Drug	N/A
168004	Rabium-DSR	Drug	N/A
168004	Rabesec-D	Drug	N/A
168004	Drego-D	Drug	N/A
168004	Rabonik DSR	Drug	N/A
168004	Razo-D	Drug	N/A
168004	Rabemac-DSR	Drug	N/A
168004	Domperidon / rabeprazole	Drug	N/A
168003	Methylcobalamin / pregabalin	Drug	N/A
168003	Mecobalamin / pregabalin	Drug	N/A
168002	Intacoxia P	Drug	N/A
168002	Etorvel-P	Drug	N/A
168002	Etowin P	Drug	N/A
168002	Etoford P	Drug	N/A
168002	Nucoxia P	Drug	N/A
168002	Etrik P	Drug	N/A
168002	Brutaflam-Plus	Drug	N/A
168002	Etoricoxib / paracetamol	Drug	N/A
168002	Etos P	Drug	N/A
168002	Acetaminophen / etoricoxib	Drug	N/A
168002	Etoril P	Drug	N/A
168002	Etoriday P	Drug	N/A
168001	Bladmir	Drug	N/A
168001	Lupin Mira	Drug	N/A
168001	Mirabig	Drug	N/A
168001	Mirasmart	Drug	N/A
168001	VesiBeta	Drug	N/A
168001	Mirbeg	Drug	N/A
168001	Miranix	Drug	N/A
168001	Myrbetriq	Drug	N/A
168001	Mirakem	Drug	N/A
168001	Mirabegron	Drug	N/A
168001	Mirago	Drug	N/A
168001	Miratas	Drug	N/A
168000	Angiotensin converting enzyme inhibitor indication present	Question	Coded
168000	Presence of indications for use of ACE inhibitor	Question	Coded
167999	Automated blood large platelet/platelet ratio	Test	Numeric
167999	Platelet-large cell ratio (P-LCR)	Test	Numeric
167998	On angiotensin-converting enzyme (ACE) inhibitors	Finding	Coded
167997	Adapalene / clindamycin	Drug	N/A
167997	Deriva-Cms	Drug	N/A
167997	Nilac A	Drug	N/A
167997	Femcinol-ADP	Drug	N/A
167997	Adaple-C	Drug	N/A
167997	Faceclin AT	Drug	N/A
167997	Acnesol A	Drug	N/A
167997	Adalene	Drug	N/A
167997	Acnovate	Drug	N/A
167997	Acnetor AD	Drug	N/A
167997	Nioclean AD	Drug	N/A
167997	167972	Drug	N/A
167996	Zesunate kit	Drug	N/A
167996	Arh plus kit	Drug	N/A
167996	Endomal SP	Drug	N/A
167996	Falciden kit	Drug	N/A
167996	Rtrit-SP combikit	Drug	N/A
167996	Artesunate + Pyrimethamine / sulfadoxine combination kit	Drug	N/A
167996	Falcynate kit	Drug	N/A
167996	Larinate kit	Drug	N/A
167996	Falciout kit	Drug	N/A
167996	Rtsunate SP	Drug	N/A
167996	Altinate kit	Drug	N/A
167995	Amoxicillin / clarithromycin / esomeprazole combination kit	Drug	N/A
167995	Sompraz HP combipack	Drug	N/A
167995	Pylokit-AC kit	Drug	N/A
167995	Esium-HP kit	Drug	N/A
167995	Nexpro HP combipack	Drug	N/A
167995	ESP-HP kit	Drug	N/A
167995	Esomac HP combo kit	Drug	N/A
167994	Clotrimazole / metronidazole	Drug	N/A
167994	Infa-V	Drug	N/A
167993	Fungin V	Drug	N/A
167993	Emplus-V	Drug	N/A
167993	Metronidazole / miconazole	Drug	N/A
167992	State (location)	Question	Text
167992	State	Question	Text
167991	Frequency of nursing observation required per hour	Question	Numeric
167990	Amlodipine / indapamide / perindopril	Drug	N/A
167990	Triplixam	Drug	N/A
167989	Hydrochlorothiazide / ramipril	Drug	N/A
167989	Ramihart-H	Drug	N/A
167989	Ramistar-H	Drug	N/A
167989	Ramcor-H	Drug	N/A
167989	Macpril H	Drug	N/A
167989	Cardace H	Drug	N/A
167989	Ramisave H	Drug	N/A
167989	Hopace-H	Drug	N/A
167988	Cerebroprotein Hydrolysate / piracetam	Drug	N/A
167988	Ceremax Plus	Drug	N/A
167988	Cerebrain Plus	Drug	N/A
167987	Cerebroprotein hydrolysate	Drug	N/A
167987	Stropin	Drug	N/A
167987	Cognifast	Drug	N/A
167987	Neurobrosin	Drug	N/A
167987	Cognistar	Drug	N/A
167987	Cerevate	Drug	N/A
167987	Zyneu	Drug	N/A
167987	Cerebrolysin	Drug	N/A
167987	Cerevion	Drug	N/A
167987	Cognitrac	Drug	N/A
167987	Cogniza	Drug	N/A
167986	Ostivestin	Drug	N/A
167986	Macvestin	Drug	N/A
167986	Rediflex	Drug	N/A
167986	Dolestin	Drug	N/A
167986	Corvestin	Drug	N/A
167986	Uniwin	Drug	N/A
167986	Univestin	Drug	N/A
167986	Lupivestin	Drug	N/A
167986	Flavestin	Drug	N/A
167986	Uniortho	Drug	N/A
167986	Visentin	Drug	N/A
167985	Cyonase-TH	Drug	N/A
167985	Loxifast	Drug	N/A
167985	Flexispaz	Drug	N/A
167985	Lorqrs T	Drug	N/A
167985	Lornoxicam / thiocolchicoside	Drug	N/A
167985	Lortag MR	Drug	N/A
167985	Relor-T	Drug	N/A
167985	Zenlong T	Drug	N/A
167985	Noxica-TH	Drug	N/A
167985	Ostiflex MR	Drug	N/A
167984	Betamethasone / chlorpheniramine	Drug	N/A
167984	Betomin	Drug	N/A
167984	Saccortin	Drug	N/A
167984	Celestamine	Drug	N/A
167984	Emperacin	Drug	N/A
167984	Celestana	Drug	N/A
167984	Histablock	Drug	N/A
167984	Puradesmin	Drug	N/A
167984	Almetamine	Drug	N/A
167984	Bedaramine	Drug	N/A
167984	Betaselemin	Drug	N/A
167983	Femiriv	Drug	N/A
167983	Orflaz	Drug	N/A
167983	Pid 3	Drug	N/A
167983	Vaginobact	Drug	N/A
167983	Azithromycin / fluconazole / ornidazole	Drug	N/A
167982	Refozi MV	Drug	N/A
167982	Remo-Zen MV	Drug	N/A
167982	Remo MV	Drug	N/A
167982	Metformin / remogliflozin etabonate / vildagliptin	Drug	N/A
167981	Vildamac M	Drug	N/A
167981	Torglip M	Drug	N/A
167981	Vildapride M	Drug	N/A
167981	Abvida-M	Drug	N/A
167981	Gliptagreat M	Drug	N/A
167981	Metformin / vildagliptin	Drug	N/A
167981	Vylda-M	Drug	N/A
167981	Galvus Met	Drug	N/A
167981	Zavamet	Drug	N/A
167981	Jalra-M	Drug	N/A
167981	Encelin M	Drug	N/A
167981	Verifica-M	Drug	N/A
167980	Alduet	Drug	N/A
167980	Cetirizine / montelukast	Drug	N/A
167980	Aleut	Drug	N/A
167979	Synriam	Drug	N/A
167979	Synriam DT	Drug	N/A
167979	Arterolane / Piperaquine	Drug	N/A
167978	Esium-HP kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167978	Espentral-HP kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167978	Clariday-kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167978	Sign kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167978	Nexiken kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167978	Nulogut HP kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167978	Nexpro HP	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167978	Esogrot-HP kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167978	Sompraz HP	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167978	Esmostrum HP kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167978	Clarithromycin / Esomeprazole / Levofloxacin combination kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167978	Pylokit-AC	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167977	Laekit h-pylori kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167977	Esose HP Kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167977	Amoxicillin / Esomeprazole / Levofloxacin combination kit	Drug	N/A	Dispensable package of three drugs used for H. pylori treatment
167976	Exospas Plus	Drug	N/A
167976	Buscodac P	Drug	N/A
167976	Belic	Drug	N/A
167976	Buscopan Plus	Drug	N/A
167976	Hyoscine butylbromide / Paracetamol	Drug	N/A
167976	Buscomide	Drug	N/A
167976	Gastreco P	Drug	N/A
167976	Hyocimax Plus	Drug	N/A
167976	Dolokind Spas	Drug	N/A
167976	Acetaminophen / hyoscine butylbromide	Drug	N/A
167976	Dolokind Spas RF	Drug	N/A
167975	Natrilam	Drug	N/A

akanter · July 14, 2023, 1:22pm

|167975|Amlodipine / indapamide|Drug|N/A||
|167975|Amlodac-D|Drug|N/A||
|167974|Nebifid AM|Drug|N/A||
|167974|Nebifast A|Drug|N/A||
|167974|Nebycare AM|Drug|N/A||
|167974|Nebivol SA|Drug|N/A||
|167974|Amlodipine / nebivolol|Drug|N/A||
|167974|Nebipil SA|Drug|N/A||
|167974|Nebilong-AM|Drug|N/A||
|167974|Nebula AM|Drug|N/A||
|167974|Nodon AM|Drug|N/A||
|167974|Nevy A|Drug|N/A||
|167974|Nebi-AM|Drug|N/A||
|167973|Late|Misc|N/A|General qualifier for something that occurred after the middle or expected time.|
|167972|On time|Misc|N/A||
|167972|Punctual|Misc|N/A||
|167971|Early|Misc|N/A|General qualifier that something occurred before the middle or expected time.|
|167970|Patient arrival timing|Question|Coded||
|167970|Patient arrival timing|Question|Coded||
|167970|Visit punctuality|Question|Coded||
|167969|Insurance number|Question|Text||

akanter · September 15, 2023, 2:53am

New version of CIEL dictionary has been added to dropbox and on Open Concept Lab for Sept 11, 2023!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.11.6, 2.0.1, 2.1, 2.2, 2.3, 2.5 and 2.5. Note that I will no longer be releasing in versions prior to 1.11

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT THE DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL.

https://app.openconceptlab.org/#/orgs/CIEL/

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release includes new concepts for COVID variants, PIH, MSF and lots of new medication concepts for the new Kenya HDD/KenyaEMR among others.

The drug table was not updated for this release. We are working on getting a new version of the drug table out, but if you are interested, reach out to me separately.

The list of new concepts (English names):

concept_id	name	Class	Datatype	description
168322	Mallampati class IV	Finding	N/A	
168322	Mallampati class 4	Finding	N/A	
168321	Mallampati class 3	Finding	N/A	
168321	Mallampati class III	Finding	N/A	
168320	Mallampati class 2	Finding	N/A	
168320	Mallampati class II	Finding	N/A	
168319	Mallampati class I	Finding	N/A	
168319	Mallampati class 1	Finding	N/A	
168318	Mallampati grade	Question	Coded	
168317	Surgical safety checklist performed	Question	Coded	
168316	Cormack and Lehane grade	Question	Coded	
168315	Cormack and Lehane grade 4	Finding	N/A	Epiglottis not visible at direct laryngoscopy.
168314	Cormack and Lehane grade 3	Finding	N/A	Epiglottis visible, vocal cords not visible at direct laryngoscopy.
168313	Cormack and Lehane grade 2	Finding	N/A	Arytenoid cartilages and posterior portion of vocal cords visible at direct laryngoscopy.
168312	Cormack and Lehane grade 1	Finding	N/A	Vocal cords visible at direct laryngoscopy.
168311	Intubated prior to arrival in operating theater	Finding	N/A	
168310	Rapid sequence induction of anesthesia	Procedure	N/A	
168309	Functional independence measure (FIM) lower limb	ConvSet	N/A	
168308	Functional independence measure (FIM) lower limb score	Question	Numeric	
168307	Functional independence measure (FIM) upper limb score	Question	Numeric	
168306	Functional independence measure (FIM) upper limb	ConvSet	N/A	
168305	Ability to walk more than fifty meters	Question	Coded	
168305	Ability to walk >50 meters	Question	Coded	
168304	Ability to walk <50 meters	Question	Coded	
168304	Ability to walk less than fifty meters	Question	Coded	
168303	Liver cirrhosis secondary to nonalcoholic steatohepatitis (NASH)	Diagnosis	N/A	
168302	Hepatic cirrhosis due to schistosomiasis	Diagnosis	N/A	
168302	Liver cirrhosis secondary to schistosomiasis	Diagnosis	N/A	
168301	Liver cirrhosis due to Hepatitis C	Diagnosis	N/A	
168300	Liver cirrhosis secondary to Hepatitis B	Diagnosis	N/A	
168300	Liver cirrhosis due to Hepatitis B	Diagnosis	N/A	
168299	Need for blood transfusion	Question	Coded	
168299	Blood transfusion needed	Question	Coded	
168298	Hepatocellular carcinoma (HCC) due to Hepatitis C	Diagnosis	N/A	2C12.02/XN1EZ
168297	Hepatocellular carcinoma (HCC) due to Hepatitis B	Diagnosis	N/A	
168296	Disease requiring admission to hospital	Question	Coded	
168296	Disease causing hospitalization	Question	Coded	
168295	History of therapeutic abdominal paracentesis	Diagnosis	N/A	
168294	Partner infected	Finding	N/A	
168294	Partner has infectious disease	Finding	N/A	
168293	Family history of infection in sibling	Diagnosis	N/A	
168293	Sibling infection	Diagnosis	N/A	
168292	Maternal infection	Diagnosis	N/A	
168291	Risk factors for Hepatitis B	Question	Coded	Presence of risk factors for personal infection with Hepatitis B.
168290	Liver palpable	Finding	N/A	
168289	Asymptomatic liver disease	Diagnosis	N/A	
168288	Aspartate aminotransferase to platelet ratio index, Serum+Blood	Test	Numeric	APRI formula = [AST /AST (ULN)]/platelet count (109/L) x 100
168288	AST to platelet ratio index (APRI), blood/serum	Test	Numeric	APRI formula = [AST /AST (ULN)]/platelet count (109/L) x 100
168287	Initial patient assessment	Procedure	N/A	
168286	injury of ureter during surgery	Diagnosis	N/A	
168286	Intra-operative injury to ureter	Diagnosis	N/A	
168285	Clinically decompensated cirrhosis of liver	Diagnosis	N/A	
168285	Clinically decompensated hepatic cirrhosis	Diagnosis	N/A	
168284	Ability to shop and carry grocery bags	Question	Coded	
168283	Ability to bake bread	Question	Coded	
168282	Visibility of squamocolumnar junction (SCJ) of uterine cervix	Question	Coded	
168281	Fully visible	Misc	N/A	
168281	Fully seen	Misc	N/A	
168280	Partially visible	Misc	N/A	
168279	History of long-term use of corticosteroids	Finding	N/A	
168278	Hand analytic mobility questions	ConvSet	N/A	
168277	Right active Kapandji clinical opposition and reposition test of thumb score	Question	Numeric	
168276	Left active Kapandji clinical opposition and reposition test of thumb score	Question	Numeric	
168275	Right passive Kapandji clinical opposition and reposition test of thumb score	Question	Numeric	Score Location achieved 1 Radial side of the proximal phalanx of the index finger 2 Radial side of the middle phalanx of the index finger 3 Tip of the index finger 4 Tip of the middle finger 5 Tip of the ring finger 6 Tip of the little finger 7 Distal interphalangeal joint crease of the little finger 8 Proximal interphalangeal joint crease of the little finger 9 Metacarpophalangeal joint crease of the little finger 10 Distal palmar crease
168274	Left passive Kapandji clinical opposition and reposition test of thumb score	Question	Numeric	"Score 	Location achieved
1 	Radial side of the proximal phalanx of the index finger
2 	Radial side of the middle phalanx of the index finger
3 	Tip of the index finger
4 	Tip of the middle finger
5 	Tip of the ring finger
6 	Tip of the little finger
7 	Distal interphalangeal joint crease of the little finger
8 	Proximal interphalangeal joint crease of the little finger
9 	Metacarpophalangeal joint crease of the little finger
10 	Distal palmar crease"
168273	Incorrect surgical count	Finding	N/A	
168272	Surgical count evaluation	Question	Coded	Whether count of instruments and sponges at the end of surgery was correct or incorrect.
168271	Incorrect	Misc	N/A	
168270	Correct	Misc	N/A	Good and proper descriptor
168269	Third finger of hand	Anatomy	N/A	
168269	Middle finger	Anatomy	N/A	
168268	Substance withdrawal syndrome	Diagnosis	N/A	
168267	Ability to eat food	Question	Coded	
168266	Ability to hold a pen	Question	Coded	
168266	Ability to hold a writing instrument	Question	Coded	
168265	Ability to oppose thumb and fifth finger	Question	Coded	
168264	Ability to unscrew a lid	Question	Coded	
168264	Ability to open a jar	Question	Coded	
168263	Ability to wash own back	Question	Coded	
168262	Ability to grab a cup of tea	Question	Coded	
168262	Ability to hold a cup of tea	Question	Coded	
168261	Functional independence measure (FIM) score	Question	Numeric	
168260	Functional independence measure (FIM)	ConvSet	N/A	
168259	Complication following amputation of limb	Question	Coded	
168259	Complication of amputation stump	Question	Coded	
168258	Phantom pain	Diagnosis	N/A	
168257	Bone spur	Diagnosis	N/A	
168257	Osteophyte	Diagnosis	N/A	
168256	Big/bulbous shape	Misc	N/A	General descriptor
168255	Small/conical shape	Misc	N/A	General descriptor
168254	Amputation stump shape	Question	Coded	Shape of amputation stump.
168253	Orthotic device	Medical supply	N/A	
168253	Orthosis	Medical supply	N/A	
168252	Ability to kneel	Question	Coded	
168251	Ability to squat	Question	Coded	
168250	Ability to lay down	Question	Coded	
168250	Ability to lie down	Question	Coded	
168249	Ability to stand up	Question	Coded	
168248	Ability to sit down	Question	Coded	
168247	Ability to sit up	Question	Coded	
168246	Ability to walk down stairs	Question	Coded	
168245	Ability to walk up stairs	Question	Coded	
168244	Description of scar	Question	Text	
168243	Complication of implantable port	Diagnosis	N/A	Any complication due to a totally implantable venous access device such as infection, mechanical failure, obstruction, thrombosis, etc.
168243	Complication of implantable venous access device	Diagnosis	N/A	Any complication due to a totally implantable venous access device such as infection, mechanical failure, obstruction, thrombosis, etc.
168242	Unanticipated admission to intensive care unit (ICU)	Procedure	N/A	
168241	Sollerman hand function test	Procedure	N/A	
168240	Sollerman hand function test score	Question	Numeric	
168239	Ability to perform household jobs	Question	Coded	
168238	Ability to engage in play/leisure activities	Question	Coded	
168237	Ability to drive a motorized vehicle	Question	Coded	
168236	Ability to use a computer keyboard and mouse	Question	Coded	
168235	Ability to operate domestic appliances	Question	Coded	
168234	Ability to operate door handle	Question	Coded	
168233	Ability to hold cutlery	Question	Coded	
168232	Ability to tie head scarf/cap	Question	Coded	
168231	Ability to put on shoes and tie laces	Question	Coded	
168230	Ability to fasten belt (for pants)	Question	Coded	
168230	Ability to fasten belt	Question	Coded	
168229	Ability to put on and take off shirt	Question	Coded	
168228	Ability to use a zipper	Question	Coded	
168227	Ability to fasten buttons	Question	Coded	
168226	Ability to shave (any body part)	Question	Coded	
168226	Ability to shave	Question	Coded	
168225	Handwashing ability	Question	Coded	
168225	Ability to wash hands	Question	Coded	
168224	Ivazine	Drug	N/A	
168224	Ivabratco	Drug	N/A	
168224	Coralan	Drug	N/A	
168224	Irban	Drug	N/A	
168224	Ivanode	Drug	N/A	
168224	Ivables	Drug	N/A	
168224	Inapure	Drug	N/A	
168224	Corlanor	Drug	N/A	
168224	Ivabrad	Drug	N/A	
168224	Ivabradine	Drug	N/A	
168224	Iverzac	Drug	N/A	
168224	Ivabeat	Drug	N/A	
168223	Bar owner	Misc	N/A	
168223	Pub owner	Misc	N/A	
168223	Publican	Misc	N/A	
168222	Pimp	Misc	N/A	
168222	Madam	Misc	N/A	
168222	Brothel keeper	Misc	N/A	
168221	Drug dealer	Misc	N/A	
168221	Drug pusher	Misc	N/A	
168221	Drug seller	Misc	N/A	
168220	Heterosexual	Finding	N/A	
168219	Sexual orientation	Question	Coded	
168218	Lornoxicam / paracetamol	Drug	N/A	
168218	Lorox P	Drug	N/A	
168218	Lornicam Plus	Drug	N/A	
168218	Lexicam	Drug	N/A	
168218	Flexilor P	Drug	N/A	
168218	Lorchek-P	Drug	N/A	
168218	Lorsaid-P	Drug	N/A	
168218	Trois	Drug	N/A	
168218	Topcam-P	Drug	N/A	
168218	Acetaminophen / lornoxicam	Drug	N/A	
168218	Lornoxi P	Drug	N/A	
168218	Lorna-P	Drug	N/A	
168217	Creatinine measurement, urine, random (mg/dL)	Test	Numeric	
168216	Ionized calcium, serum/plasma (mmol/L)	Test	Numeric	
168216	iCa2+, serum/plasma	Test	Numeric	
168215	Total thyroxine (T4), serum/plasma (nmol/L)	Test	Numeric	
168214	Total triiodothyronine (T3), serum/plasma (nmol/L)	Test	Numeric	
168213	TSH, serum/plasma	Test	Numeric	
168213	Thyrotropin, serum/plasma (uIU/mL) (mIU/L)	Test	Numeric	
168212	Serum lactate (mg/dL)	Test	Numeric	
168212	Lactate	Test	Numeric	
168211	Creatine kinase-MB measurement, blood (ng/mL)	Test	Numeric	
168211	CKMB	Test	Numeric	
168210	Free prostate specific antigen (PSA) measurement, serum/plasma (ng/mL)	Test	Numeric	
168210	f-PSA, serum/plasma	Test	Numeric	
168209	Total prostate specific antigen (PSA) measurement, serum/plasma (ng/mL)	Test	Numeric	
168209	t-PSA, serum/plasma	Test	Numeric	
168208	BA.2.86 variant	Misc	N/A	
168207	Smooth muscle Ab	Test	Coded	
168207	Smooth muscle antibody presence in blood/serum	Test	Coded	
168207	Anti-smooth muscle antibody test	Test	Coded	
168206	Dispersible oral tablet	Drug form	N/A	
168205	Eris variant	Misc	N/A	SARS-CoV-2 (COVID-19) virus variant
168205	EG.5 variant	Misc	N/A	SARS-CoV-2 (COVID-19) virus variant
168204	Magnetic resonance imaging of cervical spine	Radiology/Imaging Procedure	N/A	
168204	MRI of cervical spine	Radiology/Imaging Procedure	N/A	
168203	Magnetic resonance imaging of lumbosacral spine	Radiology/Imaging Procedure	N/A	
168203	MRI of lumbosacral spine	Radiology/Imaging Procedure	N/A	
168202	Magnetic resonance imaging of thoracolumbar spine	Radiology/Imaging Procedure	N/A	
168202	MRI of thoracolumbar spine	Radiology/Imaging Procedure	N/A	
168201	CT of hip	Radiology/Imaging Procedure	N/A	
168201	Computed tomography of hip	Radiology/Imaging Procedure	N/A	
168200	CT of femur	Radiology/Imaging Procedure	N/A	
168200	Computed tomography of femur	Radiology/Imaging Procedure	N/A	
168199	Computed tomography of knee	Radiology/Imaging Procedure	N/A	
168199	CT of knee	Radiology/Imaging Procedure	N/A	
168198	Removal of intrauterine device (IUD)	Procedure	N/A	
168198	Removal of intrauterine contraceptive device	Procedure	N/A	
168197	Luspatercept	Drug	N/A	
168197	Reblozyl	Drug	N/A	
168196	Patient Health Questionnaire Nine Modified for Adolescents score	Test	Numeric	
168196	Patient Health Questionnaire Nine Modified for Teens score	Test	Numeric	
168196	PHQ-A score	Test	Numeric	
168196	PHQ-9M score	Test	Numeric	
168195	Chronic kidney disease secondary to hypertension	Diagnosis	N/A	
168195	CKD due to HTN	Diagnosis	N/A	
168195	Chronic kidney disease due to hypertension	Diagnosis	N/A	
168194	Pediatric emergency medical service	Misc	N/A	
168193	spironolactone	Question	Coded	
168193	Taking potassium-sparing diuretic	Question	Coded	
168192	Lung function status determined by spirometry	Question	Coded	
168191	Transurethral resection of prostate (TURP)	Procedure	N/A	
168190	Subconjunctival injection	Procedure	N/A	
168189	Control of epistaxis by packing of posterior and anterior nose	Procedure	N/A	
168189	Treatment of nosebleed by packing front and back of nasal cavity	Procedure	N/A	
168188	Removal of foreign body from eye	Procedure	N/A	Removal of a foreign body from the eyeball without an incision.
168187	I&D of eyelid	Procedure	N/A	
168187	Incision and drainage of eyelid	Procedure	N/A	
168186	Irrigation of eye	Procedure	N/A	
168186	Eye washing	Procedure	N/A	
168185	Irrigation of ear	Procedure	N/A	
168185	Irrigation of external auditory canal	Procedure	N/A	
168184	Pressure ulcer assessment	Procedure	N/A	
168184	Pressure sore assessment	Procedure	N/A	
168183	Calcifediol measurement	Test	Numeric	
168183	Vitamin D3 (25-hydroxy) measurement	Test	Numeric	
168183	25-hydroxyvitamin D3 measurement	Test	Numeric	
168182	Cardiomyopathy due to viral infection	Diagnosis	N/A	
168182	Viral cardiomyopathy	Diagnosis	N/A	
168181	Tricyclic antidepressants screen, urine	Test	Coded	
168180	Propoxyphene screen, urine	Test	Coded	
168179	PCP screen, urine	Test	Coded	
168179	Phencyclidine screen, urine	Test	Coded	
168178	Oxycodone screen, urine	Test	Coded	
168177	Opiates screen, urine	Test	Coded	
168176	3,4-methylenedioxymethamphetamine screen, urine	Test	Coded	
168176	Methylenedioxymethamphetamine screen, urine	Test	Coded	
168176	MDMA urine screen	Test	Coded	
168176	Ecstasy urine screen	Test	Coded	
168175	Methamphetamine screen, urine	Test	Coded	
168174	Methadone screening, urine	Test	Coded	
168173	Cannabinoids (marijuana) screening, urine	Test	Coded	
168172	Cocaine screen, urine	Test	Coded	
168171	Buprenorphine screen, urine	Test	Coded	
168170	Benzodiazepines screen, urine	Test	Coded	
168169	Barbiturates screen, urine	Test	Coded	
168168	AMP 1000	Test	Coded	
168168	AMP screen urine	Test	Coded	
168168	Amphetamines screen, urine	Test	Coded	
168167	Drugs of abuse panel, urine	LabSet	N/A	
168166	Quviviq	Drug	N/A	
168166	Daridorexant	Drug	N/A	
168165	Loud heart murmur	Finding	N/A

akanter · October 30, 2023, 2:40pm

New version of CIEL dictionary has been added to dropbox and on Open Concept Lab for Oct 27, 2023!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.11.6, 2.0.1, 2.1, 2.2, 2.3, 2.5 and 2.5. Note that I will no longer be releasing in versions prior to 1.11

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT THE DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL.

https://app.openconceptlab.org/#/orgs/CIEL/

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release includes new concepts for PIH, MSF and lots of new medication concepts for the new Kenya HDD/KenyaEMR. To support the documentation of climate change impacts on health, it now includes many climate hazards which cause morbidity and mortality. These concepts include references to online definitions in their descriptions.

The drug table was not updated for this release. We are working on getting a new version of the drug table out, but if you are interested, reach out to me separately.

The list of new concepts (English names):

|concept_id|name|Class|Datatype|description|
|---|---|---|---|---|
|168549|Diagnosis clinical status|ConvSet|N/A||
|168549|Diagnosis status|ConvSet|N/A||
|168548|Glycort|Drug|N/A||
|168548|Gencin DM|Drug|N/A||
|168548|Biodexone G|Drug|N/A||
|168548|Pyricort|Drug|N/A||
|168548|Gentyl DM|Drug|N/A||
|168548|Gencodex|Drug|N/A||
|168548|Genta Swift D|Drug|N/A||
|168548|Dexamethasone / gentamicin|Drug|N/A||
|168548|Genticare D|Drug|N/A||
|168548|Gentapen D|Drug|N/A||
|168547|Excision of condyloma from female genitalia|Procedure|N/A||
|168546|Exploratory laparotomy with drainage of pelvic abscess|Procedure|N/A||
|168545|Laparotomy for ectopic pregnancy|Procedure|N/A||
|168545|Laparotomy for treatment of ectopic pregnancy|Procedure|N/A||
|168544|Repair of episiotomy|Procedure|N/A||
|168544|Episiorrhaphy|Procedure|N/A||
|168543|Severe nephrotic syndrome with peripheral edema|Diagnosis|N/A||
|168543|Decompensated nephrotic syndrome|Diagnosis|N/A||
|168542|History of gamete intrafallopian transfer (GIFT)|Finding|N/A||
|168541|Gamete intrafallopian transfer (GIFT)|Procedure|N/A||
|168540|History of in vitro fertilisation (IVF)|Finding|N/A||
|168540|History of in vitro fertilization (IVF)|Finding|N/A||
|168540|History of in vitro fertilization (IVF)|Finding|N/A||
|168539|In vitro fertilisation (IVF)|Procedure|N/A||
|168539|In vitro fertilization (IVF)|Procedure|N/A||
|168539|In vitro fertilization (IVF)|Procedure|N/A||
|168538|History of fertility-enhancing medication use|Finding|N/A||
|168537|History of artificial insemination|Finding|N/A||
|168536|Vaginal delivery after previous cesarean delivery (VBAC) with use of vacuum|Procedure|N/A||
|168536|Vacuum delivery following previous cesarean delivery|Procedure|N/A||
|168535|Vaginal delivery after previous cesarean delivery (VBAC) with use of forceps|Procedure|N/A||
|168535|Forceps delivery after previous cesarean delivery|Procedure|N/A||
|168534|Failed external cephalic version|Finding|N/A||
|168533|History of tocolytic therapy|Finding|N/A||
|168532|Administration of tocolytics|Procedure|N/A||
|168532|Tocolysis|Procedure|N/A||
|168531|Cervical cerclage|Procedure|N/A||
|168531|Cerclage of uterine cervix|Procedure|N/A||
|168530|Physical therapy consultation recommendation|Question|Coded||
|168530|Normens|Question|Coded||
|168530|Mendate|Question|Coded||
|168530|Crina-NCR|Question|Coded||
|168530|Noristerat|Question|Coded||
|168530|Nortas|Question|Coded||
|168530|Primolut-N|Question|Coded||
|168530|Norcolut|Question|Coded||
|168530|Norgest|Question|Coded||
|168530|Cycloreg|Question|Coded||
|168530|Norethisterone|Question|Coded||
|168530|Regestrone|Question|Coded||
|168530|Gynaset|Question|Coded||
|168530|Ncnorm p|Question|Coded||
|168530|Sysron-N|Question|Coded||
|168530|Normonal|Question|Coded||
|168529|Societal hazards and causes of injury|ConvSet|N/A||
|168528|Financial shock|Misc|N/A|A financial shock is an unexpected disturbance which originates from the financial sector and has a significant effect on an economy (e.g. national, regional, or global). The term is largely used to refer to events which have negative impacts (ECB, 2013).|
|168528|Economic shock|Misc|N/A|A financial shock is an unexpected disturbance which originates from the financial sector and has a significant effect on an economy (e.g. national, regional, or global). The term is largely used to refer to events which have negative impacts (ECB, 2013).|
|168527|Human stampede|Misc|N/A|Stampede or crushing is the surge of individuals in a crowd, in response to a perceived danger or loss of physical space. It often disrupts the orderly movement of crowds resulting in irrational and dangerous movement for self-protection leading to injuries and fatalities (Illiyas et al., 2013).|
|168526|Environmental degradation from conflict|Misc|N/A|Environmental degradation from conflict is defined as the reduction of the capacity of the environment to meet social and ecological objectives and needs (UNISDR, 2009:6).<br>REF: www.undrr.org/publication/2009-unisdr-terminology-disaster-risk-reduction|
|168525|Explosive remnants of war|Misc|N/A|Explosive remnants of war are unexploded ordnance and abandoned explosive ordnance that are left by a party to an armed conflict following the cessation of warfare. Explosive ordnance is defined as conventional munitions containing explosives (United Nations, 2004:2).<br>REF: https://treaties.un.org/doc/Treaties/2003/11/20031128%2001-19%20AM/Ch_XXVI_02_dp.pdf|
|168525|Abandoned explosive ordnance|Misc|N/A|Explosive remnants of war are unexploded ordnance and abandoned explosive ordnance that are left by a party to an armed conflict following the cessation of warfare. Explosive ordnance is defined as conventional munitions containing explosives (United Nations, 2004:2).<br>REF: https://treaties.un.org/doc/Treaties/2003/11/20031128%2001-19%20AM/Ch_XXVI_02_dp.pdf|
|168525|Unexploded ordnance|Misc|N/A|Explosive remnants of war are unexploded ordnance and abandoned explosive ordnance that are left by a party to an armed conflict following the cessation of warfare. Explosive ordnance is defined as conventional munitions containing explosives (United Nations, 2004:2).<br>REF: https://treaties.un.org/doc/Treaties/2003/11/20031128%2001-19%20AM/Ch_XXVI_02_dp.pdf|
|168524|Civil unrest|Misc|N/A|&quot;Civil unrest&quot; is an umbrella term for a wide spectrum of phenomena, and although there is no commonly agreed United Nations definition the term is used widely among United Nations agencies, funds and programmes, particularly to describe violent and non-violent group acts.<br>A suggested definition for &quot;civil unrest&quot; is as follows: a term that includes limited political violence (such as acts of &lsquo;terrorism&rsquo;, individual assassinations, etc.), sporadic violent collective action (such as riots), or nonviolent and mildly violent collective action (such as protests, demonstrations, etc.) &ndash; all of which tend to take place in times of peace (Kalyvas, 2000:3).|
|168523|Internal armed conflict|Misc|N/A|Non-international armed conflict is defined as protracted armed confrontations occurring between governmental armed forces and the forces of one or more armed groups, or between such groups arising on the territory of a State. The armed confrontation must reach a minimum level of intensity, and the parties involved in the conflict must show a minimum of organisation (ICRC, 2008).|
|168523|Non-international armed conflict (NIAC)|Misc|N/A|Non-international armed conflict is defined as protracted armed confrontations occurring between governmental armed forces and the forces of one or more armed groups, or between such groups arising on the territory of a State. The armed confrontation must reach a minimum level of intensity, and the parties involved in the conflict must show a minimum of organisation (ICRC, 2008).|
|168523|Non-international war|Misc|N/A|Non-international armed conflict is defined as protracted armed confrontations occurring between governmental armed forces and the forces of one or more armed groups, or between such groups arising on the territory of a State. The armed confrontation must reach a minimum level of intensity, and the parties involved in the conflict must show a minimum of organisation (ICRC, 2008).|
|168522|International armed conflict (IAC)|Misc|N/A|International armed conflict covers all cases of declared war and other de facto armed conflict between two or more States, even if the state of war is not recognised by one of them and/or the use of armed force is unilateral (ICRC, 2016).|
|168522|International war|Misc|N/A|International armed conflict covers all cases of declared war and other de facto armed conflict between two or more States, even if the state of war is not recognised by one of them and/or the use of armed force is unilateral (ICRC, 2016).|
|168522|State-based armed conflict|Misc|N/A|International armed conflict covers all cases of declared war and other de facto armed conflict between two or more States, even if the state of war is not recognised by one of them and/or the use of armed force is unilateral (ICRC, 2016).|
|168522|Inter-state war|Misc|N/A|International armed conflict covers all cases of declared war and other de facto armed conflict between two or more States, even if the state of war is not recognised by one of them and/or the use of armed force is unilateral (ICRC, 2016).|
|168521|Environmental hazards and causes of injury|ConvSet|N/A||
|168520|Environmental eutrophication|Misc|N/A|Eutrophication is the overabundance of nutrients in a body of water that results in harmful algal blooms, fish kills, and in some cases ecosystem collapse. It is a process driven by enrichment of water by nutrients, particularly compounds of nitrogen and/or phosphorus, leading to increased growth, primary production and biomass of algae; changes in the balance of nutrients causing changes to the balance of organisms; and water quality degradation (NOAA, 2007; UNEP, 2015).|